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ABSTRACT
 B: Acute lung injury (ALI) 
is a stereotypic inflammatory reaction 
of the lung to various insults. Acute lung 
injury and its more severe form, acute 
respiratory distress syndrome (ARDS), 
cause respiratory failure, the most com-
mon organ failure leading to intensive care. 
Treatment modalities of ALI remain mainly 
supportive. One of the most widely used 
pharmacological treatments is the use of 
glucocorticosteroids. Glucocorticosteroids 
during the initial phase of ALI have been 
shown to be potentially harmful, but dur-
ing the later fibroproliferative phase several 
studies indicate a potential benefit. Benefits 
of this concept have not been investigated 
with a homogenous group of ALI patients. 
In ALI, the mainstay of supportive therapy 
is ventilatory treatment. Ventilatory settings 
aimed at protecting the lung from possible 
iatrogenic injury may improve outcome of 
ALI patients. e use of prone positioning 
(PP) is a non-ventilatory method which has 
been shown to improve gas exchange in 
ALI. Partial ventilatory modes, which allow 
a patient’s spontaneous breathing activity, 
may improve physiological variables of gas 
exchange and haemodynamics, particularly 
with airway pressure release ventilation 
(APRV), a ventilatory mode with unsup-
ported spontaneous ventilation superim-
posed on mechanical ventilation. No study 
has investigated the possible outcome ben-
efit of a ventilatory strategy combining lung 
protective ventilation, PP, and APRV.
P  : In all, 89 ALI pa-
tients were studied during the years 1996 
to 2001 in the mixed intensive care unit 
of Meilahti Hospital (Helsinki University 
Central Hospital). Use of APRV together 
with prone positioning was described in 
one severe ARDS patient (Study I). In a 
randomised controlled trial, APRV was 
compared to another partial ventilatory 
mode, synchronised intermittent manda-
tory ventilation (SIMV), with 58 ALI patients 
(Study II). Prone positioning was part of 
a standardised treatment protocol, and 
combined effects of APRV and prone posi-
tion were investigated during two initial 
prone position episodes on 33 patients 
(Study III). Computer tomography (CT) of 
the lung was performed before inclusion in 
the trial. ose patients (n = 23) requiring 
mechanical ventilation after 7 days under-
went control CT. Changes in quantitative CT 
scan were analysed in a subgroup of Study 
II (Study IV). In the final study, 31 patients 
with primary ALI and prolonged mechani-
cal ventilation were retrospectively anal-
ysed. Of these patients, 16 received steroid 
treatment for a presumed fibroproliferative 
reaction. A comparable group of 15 patients 
was designated as a control group (Study 
V).
M : In the randomised trial 
comparing APRV to SIMV, the primary end-
point was number of ventilator free-days 
after randomisation to the study. At day 
28, the number of both ventilator-free days 
(13.4 ± 1.7 in the APRV group and 12.2 ± 1.5 
in the SIMV group) and ICU-free days did 
not differ between the groups. Inspiratory 
pressure during the first week of study was 
significantly lower in the APRV group (25.9 
± 0.6 cmH₂O) than in the control group (28.6 
± 0.7 cmH₂O). e 28-day mortality was low 
in both groups, 17 % in the APRV group and 
18 % in the SIMV group (n.s.) (Study II).
Per protocol, PP was applied if PaO₂/FiO₂ 
decreased below 200 mmHg, and if not 
contraindicated. e first two episodes 
were analysed in 33 patients. Oxygenation 
was significantly better in the APRV group 
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before the first episode; response to prone 
positionining in both groups was similar. 
Before the second episode the PaO₂/FiO₂ 
ratio was comparable. At the end of the 
second episode PaO₂/FiO₂ ratio improved 
more in the APRV group than in the SIMV-
group (p = 0.02) (Study III).
CT scans in 23 patients showed the de-
crease in the amount of nonaerated lung to 
be comparable between the groups: 12.1 ± 
4.3 % in the APRV group (n = 13) and 7.2 ± 
5.7 % in the SIMV group (n = 10) (Study IV). 
In patients with primary ALI, steroid 
treatment was started 9.7 days (mean) after 
ICU admission. Values for the controls were 
recorded on day 10. Within 3 days of this 
reference point, the PaO₂/FiO₂ ratio im-
proved significantly and C-reactive protein 
decreased concurrently, together with mul-
tiple organ dysfunction score in the group 
receiving steroids. Neither mortality nor 
length of stay differed between the groups 
(Study V).
C: is study showed that 
APRV used as a primary ventilatory mode 
in ALI is a feasible strategy, and mortal-
ity with a group of ALI/ARDS patients is 
low. No differences appeared in relevant 
clinical outcome as compared to those with 
the strategy utilising SIMV. e use of PP 
together with APRV may have a beneficial, 
synergistic effect on oxygenation. e effect 
of ventilatory mode on lung consolidation 
assessed with CT after 7 days was similar 
to that of APRV and of SIMV. In primary 
ALI, steroid treatment instituted after 10 
days of the start of the ALI process improves 
oxygenation, alleviates the inflammatory 
reaction, and is associated with a decrease 
in multiorgan dysfunction.
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ABBREVIATIONS
ACV Assist/control ventilation 
AECC American-European consensus 
conference
ALI  Acute lung injury
APACHE Acute physiology and chronic 
health evaluation
APRV Airway pressure release ventila-
tion
ARDS Acute respiratory distress syn-
drome 
BAL Bronchoalveolar lavage
BIPAP Bilevel airway pressure ventila-
tion
CPAP Continuous positive airway 
pressure
CT Computer tomography
DAD Diffuse alveolar damage
FIO₂ Fraction of inspired oxygen
HFV High frequency ventilation
HU Hounsfield unit
ICU Intensive care unit
IL Interleukine
IMV  Intermittent mandatory ventila-
tion
IRV Inverse ratio ventilation
LIP Lower inflection point 
LIS Lung Injury Score
MOD Multiple organ dysfunction
MODS Multiple organ dysfunction 
score
MOF Multiple organ failure
MV Minute ventilation
PAC Pulmonary artery catheter
PaO₂ Arterial oxygen partial pressure
PaCO₂ Arterial carbon dioxide partial 
pressure
PaO₂/FiO₂ ratio
 Ratio of oxygen partial pressure 
and fraction of inspired oxygen 
PCWP Pulmonary capillary wedge 
pressure
PEEP Positive end expiratory pressure
Pinsp Inspiratory airway pressure
PP Prone positioning
PS Pressure support ventilation
PV-curve Pressure volume curve
Qs/Qt  Intrapulmonary shunt
ROI Region of interest
SIMV-PC Synchronized intermittent man-
datory ventilation with pressure 
control
SOFA Sequential organ failure assess-
ment
UIP Upper inflection point
VALI Ventilator-associated lung 
injury
VFD Ventilator-free days
VILI Ventilator induced lung injury
V/Q ratio Ventilation-perfusion ratio
VT Tidal volume
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1. INTRODUCTION
Acute lung injury (ALI) and its more severe 
form ARDS represent major causes of acute 
respiratory failure in critically ill patients 
(Roupie, et al. 1999). Respiratory failure, 
“the clinical hallmark” of these syndromes, 
is the most common cause for admission 
to an intensive care unit (ICU). Historically, 
because specialized units equipped to mon-
itor and treat critically ill patients were ini-
tially developed to treat patients with acute 
respiratory insufficiency (Trubuhovich 
2004), one can state that respiratory failure 
and its treatment modalities constitute the 
essential part of modern critical care.
ALI is an inflammatory reaction of the 
lungs characterized by activation of several 
cascades. is complex pathophysiological 
process results in structural and functional 
alterations of the lungs characterized by 
impairment of gas exchange, of respira-
tory mechanics, and of oxygen delivery. 
is inflammatory reaction can be initiated 
by direct pulmonary injury or by indirect 
systemic insult. In both circumstances, 
the inflammatory process leads ultimately 
to diffuse alveolar damage via complex 
interactions of inflammatory mediators on 
alveolar epithelial and capillary endothelial 
cells (Ware and Matthay 2000). Pulmonary 
inflammation leads to systemic response 
and development of extrapulmonary organ 
failure. Progression of end organ dysfunc-
tion to multiple organ failure is the main 
cause of death in ALI patients (Slutsky and 
Tremblay 1998). Mortality from ALI/ARDS 
has remained high, ranging from 30 to 70 % 
(Esteban, et al. 2002, Milberg, et al. 1995).
e most essential part of the supportive 
treatment of ALI patients is treatment of gas 
exchange failure. Practically all patients 
with ALI require assisted positive pressure 
ventilation in order to reverse respiratory 
failure. As with any treatment, mechanical 
ventilation can have side-effects and un-
wanted consequences. Mechanical ventila-
tion can cause further damage to the lung, 
exacerbate systemic inflammation, and 
lead to extrapulmonary organ dysfunction 
(Dreyfuss and Saumon 1998, Slutsky and 
Tremblay 1998). Providing ventilatory treat-
ment without causing unnecessary harm 
improves outcome of ALI (Anonymous 
2000), but several aspects, such as ventila-
tory mode, are still controversial (Tobin 
2001). Interfacing with the patient’s efforts 
and with the ventilator’s contribution can 
be arranged in various ways with modern 
technology (Tobin 2001), enabling the use 
of partial ventilatory techniques in the early 
phases of ALI (Cereda, et al. 2000, Putensen, 
et al. 2001). Achieving satisfactory gas 
exchange even in severe ARDS patients is 
feasible with these modes, but benefits of 
these strategies for outcome are unproven 
(Cereda, et al. 2000).
e main outcome measure in the inter-
ventional trials concerning ALI has been 
either mortality or a surrogate of mortality, 
e.g., time of mechanical ventilation or days 
free of ventilation and being alive after in-
clusion in the trial (Schoenfeld, et al. 2002). 
Statistically, demonstrating of the effect of 
intervention on mortality requires a large 
and homogenous patient population with 
a strictly standardised protocol for various 
aspects of critical care. For smaller groups, 
physiological outcome variables, related 
to the pathophysiology of ALI, are needed 
(Wyncoll and Evans 1999, Vincent 2004). 
When the effects of ventilatory technique 
are investigated, variables related to gas 
exchange are commonly scrutinized, all-
though relationships between gas exchange, 
extent of lung injury and outcome are not 
straightforward. Computer-assisted x-ray 
tomography (CT) is an option for assessing 
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the extent of lung injury, has proven a good 
tool in the evaluation of ALI pathophysiol-
ogy (Gattinoni, et al. 2001a). Several aspects 
related to lung injury may be measured with 
CT (Rouby, et al. 2003a).
Historically, very soon after the descrip-
tion of the inflammatory nature of ALI, 
modulation of the inflammatory reaction 
was considered as a treatment option (Luce 
2002). e most investigated intervention 
in this sense has been anti-inflammatory 
drugs, and especially glucocorticosteroids. 
Although administration of glucocor-
tico-steroids during early phases of ALI has 
proven to be disadvantageous (Bernard, et 
al. 1987, Cronin, et al. 1995), several studies 
have implied that in the late phase of ALI, 
the inflammatory process is characterised 
by a fibroproliferative reaction, and glu-
cocorticosteroids may be effective during 
this phase (Meduri 1999). However, specific 
indications for glucocorticosteroid treat-
ment and its contribution to outcome in 
late-phase ALI are still obscure.
In this study, the aim was to evaluate 
current treatment modalities of ALI, par-
ticularly the maintenance of spontaneous 
ventilation during mechanical ventilation 
and effects of glucocorticosteroids in the 
late phase of lung injury. A randomised 
and controlled study design was used to 
assess physiological effects and outcome 
measures comparing two different partial 
ventilatory modes. Airway pressure release 
ventilation (APRV), which is a partial 
ventilatory mode enabling unrestricted 
unsupported spontaneous breathing super-
imposed on mechanical ventilation was the 
primary focus. APRV has not been tested in 
a randomised, parallel, controlled setting 
with ALI/ARDS patients. e control mode 
was the present gold standard syncronised 
intermittent ventilation (SIMV).
Moderate-dose, prolonged glucocortico-
steroid treatment during the late phase of 
ALI is currently the only clinical treatment 
option aimed at modulating the inflam-
matory reaction. e clinical benefit of this 
strategy was analysed in a homogeneous 
group of ALI patients.
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2. REVIEW OF THE LITERATURE
2.1 Definitions of ALI and ARDS
Acute lung injury was first described as 
a clinical syndrome by Ashbaugh et al in 
1967, who presented a case series of twelve 
patients with common clinical hallmarks. 
ese signs were acute respiratory distress, 
hypoxia refractory to oxygen, diffuse bilat-
eral pulmonary infiltrates, reduced compli-
ance of the respiratory system, and require-
ment of positive pressure breathing. Patients 
suffered from a variety of serious illnesses 
and had severe respiratory failure requiring 
mechanical ventilation (Ashbaugh, et al. 
1967). Autopsies of the patients who died, 
showed hyaline membranes in the airways, 
atelectasis, microthrombosis, vascular 
congestion and fibrosis (Wyncoll and Evans 
1999). e same investigators proposed the 
term “adult respiratory distress syndrome” 
(ARDS), an analogue to the infant respira-
tory distress syndrome (Petty and Ashbaugh 
1971).
To more precisely define this group of 
patients with strikingly uniform clinical, 
physiological, radiological, and pathologi-
cal abnormalities, the original investigators 
proposed a definition for ARDS. is defini-
tion was based on the presence of hypoxia, 
chest radiographical opacities, decreased 
mechanical properties of the respira-
tory system, and exclusion of congestive 
left heart failure (Petty and Ashbaugh 
1971). A very important feature of this and 
several subsequent definitions has been the 
presence of a triggering insult or a known 
risk factor. Almost any critical illness or 
catastrophic insult to homeostasis is such 
a risk factor. Table 1 presents common 
clinical entities associated with ALI. Most 
definitions of ALI/ARDS have underlined 
the acute nature of this clinical problem, 
and the original term “adult respiratory dis-
tress syndrome” has been replaced with the 
term “acute respiratory distress syndrome” 
(Bernard, et al. 1994b). Another reason is 
the fact that ALI/ARDS also affects paedi-
atric patients.
e definition advocated by Murray et al 
incorporated a quantitative scoring system 
for lung injury with classified variables 
based on radiographical appearance of the 
lung on chest x-ray, static lung compliance, 
positive end expiratory pressure (PEEP) 
setting, and ratio of arterial partial oxygen 
pressure and fraction of inspired oxygen 
(Murray, et al. 1988). e Murray score or 
Lung Injury Score (LIS) has been widely 
used in epidemiological studies as well as in 
several interventional studies. e benefit 
of this definition is that the severity of lung 
injury can be quantified, and LIS can be 
used to compare patients at different time 
points. In the original work by Murray et 
al ARDS was defined as a LIS over 2.5, and 
mild to moderate injury as values between 
0.1 – 2.5 (Murray, et al. 1988). LIS scoring is 
presented in Table 2.
e final value is obtained by dividing the 
Table 1. Clinical entities associated with 
acute lung injury. (Modified from Ware 
and Matthey 2000).
Direct lung injury or pulmonary ALI 
 Pneumonia
 Gastric content aspiration
 Pulmonary contusion
 Inhalation of toxic gases
 Near-drowning
Indirect lung injury or extrapulmonary ALI
 Sepsis
 Pancreatitis
 Multiple transfusions
 Severe trauma
 Severe burns
 Drug overdose
 Cardiopulmonary by-pass
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sum of these individual component scores 
by 4.
e lack of uniform criteria which could 
form the basis of epidemiological and 
interventional studies and a better strati-
fication of patients served as the initiative 
for the American-European Consensus 
Conference (AECC) to create a simple and 
a widely accepted definition (Bernard, et 
al. 1994b). is definition incorporated the 
term “Acute Lung Injury” (ALI). According 
to this concept, ALI is considered to be “a 
syndrome of inflammation and increased 
permeability that is associated with a 
constellation of clinical, radiological, and 
physiological abnormalities that cannot be 
explained, but may coexist with congestive 
heart failure or pulmonary capillary hy-
pertension”. An essential part of the AECC 
definition is that the onset of the insult must 
be acute, but no exact time frame for acute 
illness has yet been presented. According 
to the AECC criteria, ARDS is an extreme 
manifestation of ALI, and degree of hypox-
emia separates ARDS patients from those 
with ALI (Bernard, et al. 1994b). e AECC 
criteria are presented in Table 3.
Comparision of AECC and LIS clas-
sifications yielded similar estimates of the 
incidence of ARDS, although with a dis-
crepancy between the classifications, and 
neither had any prognostic value (Meade, 
et al. 2001).
e aim of the development of AECC 
criteria was to simplify and to make easier 
clinical application of the definition of ALI/
ARDS. A critique of straightforward evalua-
tion of the oxygenation defect in the AECC 
criteria has been presented. It has been sug-
gested that this evaluation should be with a 
determined specific PEEP or with otherwise 
optimised respiratory settings (Villar, et al. 
1999). Application of or increase in PEEP 
can easily, for example, turn an ARDS pa-
tient with a Pa
2
/FiO
2
 ratio of just below 200 
mmHg into an ALI patient or even increase 
the PaO₂/FiO₂ ratio above 300 mmHg (Villar, 
et al. 1999). To emphasise the inflammatory 
nature of ALI, incorporation of biochemical 
markers of inflammation into the definition 
of ALI has also been suggested (Abraham, 
et al. 2000). Making the definition more 
specific may require more a precise defini-
tion of radiographical criteria or the use of 
computed tomography of the lung (Roupie, 
et al. 1999).
Table 3. AECC criteria for ALI and ARDS (Bernard, et al. 1994a).
1. Acute onset
2. Bilateral infiltrates on chest radiography
3. Pulmonary artery wedge pressure < 18 mmHg or the absence of clinical evidence of   
 left atrial hypertension
4. Failure of oxygenation
  a. Acute lung injury considered to be present if PaO2/FiO2 is ≤ 300 mmHg
  b. Acute respiratory distress syndrome considered to be present if PaO2/FiO2 is ≤ 200 mmHg
Table 2. Lung injury score (LIS). (Adapted from Murray et al 1988).
Component 0 1 2 3 4
Chest X-ray
(Alveolar infiltrates) No 1 quadrant 2 quadrants 3 quadrants 4 quadrants
Hypoxaemia
(PaO2/FiO2, mmHg)
≥ 300 225 – 299 175 – 224 100 – 174 ≤ 100
PEEP
(PEEP-setting, cmH2O
≤ 5 6 – 8 9 – 11 12 – 14 ≥ 15
Compliance
(Static, mL/cmH2O)
≥ 80 60 – 79 40 – 59 30 – 39 ≤ 29
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2.2 Epidemiology of ALI/ARDS
Since the time of the description of ALI/
ARDS, it has been difficult to estimate 
the incidence of this clinical syndrome. 
A precise and uniform definition is of 
outmost importance for epidemiological 
studies. Earlier epidemiological reports 
have used ambiguous definitions, and the 
reported incidence of ARDS has varied 
between 1.5 (Villar and Slutsky 1989) and 
60 (Anonymous 1977) cases per 100 000 
inhabitants. In more recent prospective 
cohort studies which have used the AECC 
criteria, the reported incidence of ALI has 
ranged from 34 to 64.2 cases per 100 000 
and for ARDS 28 cases per 100 000/year 
(Bersten, et al. 2002) (Goss, et al. 2003). In 
a Nordic cohort study, the reported inci-
dences of ALI and ARDS were much lower, 
with only 17.9 per 100 000/year for ALI and 
13.5 per 100 000/year for ARDS (Luhr, et al. 
1999). In that study, only those patients who 
were mechanically ventilated over 24 hours 
were screened. is could have led to un-
derestimation of the incidence. In a recent 
multicenter survey prevalence of acute lung 
injury was 7.1 % in a sample of European 
ICUs (Brun-Buisson, et al. 2004).
e only Finnish study reporting the 
incidence of ARDS is the study conducted 
by Valta et al. (Valta, et al. 1999). By using 
strict criteria for ARDS, and by demanding a 
PaO₂/FiO₂ ratio below 150 mmHg with FiO₂ 
> 0.5, PEEP > 5 cmH₂O, and LIS score > 2.5, 
the incidence of ARDS in Savonia was 4.9 
per 100 000/year (Valta, et al. 1999).
e role of the underlying condition and 
its risk of progression to ALI is a poorly un-
derstood issue. Only a few studies have tried 
to identify patients at risk for ALI/ARDS and 
tried to determine the incidence of develop-
ment of ARDS in these clinical situations. 
No study has used AECC criteria (Hudson, 
et al. 1995). Clinical situations related to 
ARDS are so diverse that studies including 
enough patients in defined groups are dif-
ficult to conduct.
2.3 Pathogenesis of ALI
2.3.1 Pathogenetical features of 
lung injury
e clinical course of ALI can usually be 
divided into three phases with typical clini-
cal, physiological, and histological patterns 
(Ware and Matthay 2000). However, as the 
triggering insults are variable, the typical 
presentation and progression of the syn-
drome is difficult to define. Also, especially 
after the initial phase of the inflammatory 
reaction, considerable heterogeneity exists 
in the pathogenesis and clinical progression. 
For reasons related to underlying disorders, 
patient-related factors, and treatment or all 
of these, not all patients progress through all 
the phases (Weinacker and Vaszar 2001).
e basic pathology of ALI/ARDS during 
the initial phase comprises a non-specific 
pattern of lung injury leading to increased 
permeability of the endothelial and epithe-
lial barriers of the lung, with accumulation 
of the protein-rich oedema fluid in the 
interstitium and alveoli. is initial phase or 
early ARDS is therefore called the exudative 
phase (Ware and Matthay 2000). e fluid 
accumulation is accompanied by neutro-
phil sequestration and migration as a result 
of chemotactic stimuli released within the 
lung and the activation of neutrophils by lo-
cal and circulating inflammatory mediators 
(Pittet, et al. 1997). Histologically, injury or 
even necrosis of alveolar type I epithelial 
cells may be seen. is pattern of injury is 
described as diffuse alveolar damage (DAD) 
(Luce 1998). Numerous cascades of media-
tors, modulators, and inflammatory cells are 
involved in this process (Pittet, et al. 1997). 
e relative importance of these compo-
nents is unknown, and the pathogenesis of 
lung injury may involve several alternative 
pathways. Some of the basic pathways in-
volved during initial phase of ALI are sum-
marized in Figure 1.
Some patients recover quickly within a 
few days after the initial defect of alveoli-
endothelial permeability and do not enter 
the subsequent phases of inflammatory 
injury. Some patients, however, move after 
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5 to14 days to the second or proliferative 
phase of lung injury, a phase character-
ized by marked proliferation of fibroblasts 
in the alveoli. e proliferation of alveolar 
type II cells leads to interstitial fibrosis, and 
the obstruction and destruction of the pul-
monary capillary circulation (Lee and Jain 
2002). Recent data suggest that the fibrop-
roliferative response may begin early in the 
course of ALI (Marshall, et al. 2000). In some 
patients the proliferative phase evolves to a 
third phase, the chronic fibrotic phase of 
ALI. is phase, commonly referred to as 
late ARDS, usually develops beyond 10 days 
after the initial insult and is characterized 
by extensive fibrosis with obliteration of 
the normal lung structure, development 
of emphysematous lung regions, and bulla 
(Artigas, et al. 1998). 
e basic mechanisms that control the 
progression of ongoing lung injury and the 
factor, which regulates inflammatory pro-
cess are not yet fully understood (Bellingan 
2002). Extremely complex interactive regu-
latory signals pose a significant challenge 
to developing treatments which would 
have beneficial effects on the course of the 
inflammatory reaction and outcome.
2.3.2 Ventilator-induced lung injury
Treatment of ALI, and especially the ap-
plication of mechanical ventilation, have 
several consequences for the pathophysiol-
ogy of lung injury. Besides being life-saving 
supportive treatment of respiratory failure, 
just as with any treatment, mechanical 
ventilation also has side-effects. After only 
3 years after the description of ARDS, came 
the first reports speculated that mechanical 
ventilation may cause iatrogenic injury to 
the lungs through the non-uniform expan-
sion of the injured lung (Mead J 1970). 
Barotrauma, the leakage of air due to 
disruption of the airspace wall, and hae-
modynamic compromise due to decrease of 
cardiac filling are complications recognised 
ever since the development of positive pres-
sure breathing (Pontoppidan, et al. 1972). 
Subtler, iatrogenic injury caused to the lung 
by mechanical ventilation is a concept that 
is defined as “ventilator-associated lung 
injury” (VALI) (Pinhu, et al. 2003). When 
induced in an animal model by injurious 
mechanical ventilation alone, the term 
ventilator-induced lung injury (VILI) is rec-
ommended (Anonymous 1999). e contri-
Figure 1. (Modified from Bulger et al 2001).
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bution of VALI to the pathogenesis of lung 
injury is inseparable and indistinguishable 
from the underlying disorder (Dreyfuss and 
Saumon 1998).
e underlying mechanisms contribut-
ing to VILI are well established in several 
experimental investigations (Dreyfuss and 
Saumon 1998). Factors involved in this 
process include high inspired oxygen con-
centration, high pressure and volumes, tidal 
collapse, and reinflation of the lung during 
mechanical ventilation. It has been suggest-
ed that these factors should be categorised 
into five distinct components: barotrauma, 
volutrauma, atelectotrauma, biotrauma, 
and toxic effects of oxygen (Pinhu, et al. 
2003). 
Although the toxic effects of oxygen 
due to increased formation of oxygen free 
radicals have been demonstrated in sev-
eral experimental models (Dreyfuss and 
Saumon 1998), the threshold for pulmonary 
oxygen toxicity in humans and particularly 
those with ALI is unknown. However, the 
lowest possible concentration of oxygen 
that relieves tissue hypoxia is commonly 
recommended (Jenkinson 1993). In pa-
tients with normal lungs, even prolonged 
exposure to high oxygen concentrations has 
not been associated with increased mark-
ers of lung injury (Capellier, et al. 1998). 
A high oxygen concentration may cause 
atelectasis formation due to absorption in 
areas with a low ventilation-perfusion ratio 
and hence may worsen the gas-exchange 
(Hedenstierna 1999). To avoid hypoxia, 
high concentrations of oxygen are, however, 
usually needed in ventilatory treatment of 
ALI. e relationship between toxic effects 
of oxygen and detrimental effects of hypoxia 
remain unknown.
High airway pressure was initially con-
sidered the major factor causing unfavour-
able side-effects related to mechanical 
ventilation. Macroscopic accumulation 
of extra-alveolar air is a gross manifesta-
tion of barotrauma. Clinically, this kind of 
barotrauma presents as pneumothorax, 
pneumomediatinum, pneumatocele, sub-
cutaneous emphysema, and even gas em-
bolism, but no correlation between clinical 
barotraumas and airway pressure has been 
firmly established (Weg, et al. 1998). Airway 
pressure is not a particularly good surro-
gate for alveolar pressure, and peak airway 
pressure in partcular highly influenced 
by several factors affecting lung and chest 
wall mechanics. Because airway pressure is 
dependent on mechanical properties of the 
respiratory system, barotrauma and volu-
trauma may be viewed as two aspects of the 
same phenomenon (Gattinoni, et al. 2003). 
e term volutrauma was suggested to in-
dicate that the critical factor causing injury at 
cellular level is excessive volume rather than 
high transpulmonary pressure (Dreyfuss 
and Saumon 1998). is was demonstrated 
by strapping the chest wall of experimental 
animals and ventilating them at high pres-
sures, but low tidal volumes. In this setting, 
lung injury remained moderate, but similar 
airway pressures without strapping and 
the inevitable high tidal volumes can lead 
to increased permeability and pulmonary 
oedema. Several other experimental trials 
have shown that overstretching of the lung’s 
fibroskeleton causes direct physical damage 
to alveolar-capillary structures, leading to 
increased permeability and disruption of al-
veolar and endothelial structures (Dreyfuss 
and Saumon 1998). Molecular pathways in-
volved in signal transduction in this process 
are complex and still poorly understood. 
Regional transpulmonary pressures control 
distribution of overstretching. Lung weight 
promotes the collapse of dependent areas, 
causing a marked decrease in regional 
transpulmonary pressure (Gattinoni, et al. 
1993). Chest wall derangements, the weight 
of mediastinal structures, and increased 
intra-abdominal pressure may also lead 
to regional variation in transpulmonary 
pressure. Distribution of ventilation is 
determined by this regional variation, and 
ventilation has a preference for the areas of 
least intrapleural pressure such as the ante-
rior parts of the thorax in a supine patient. 
Hence, these areas are prone to volutrauma. 
Proof of this injury caused by overdistension 
is evident radiologically and histologically. 
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Cystic changes in lung parenchyma, bulla, 
and fibrosis have a tendency to develop 
into anterior parts of the lung (Desai, et al. 
1999).
Atelectotrauma refers to shearing injury 
caused by recruitment and de-recruitment 
within the respiratory cycle (Dreyfuss and 
Saumon 1998). Mechanical force gener-
ated at the junction of areas with different 
mechanical properties is called shear stress. 
Traction forces generated between col-
lapsed alveoli and adjacent expanded lung 
units have been predicted in a mathematical 
model to exceed 100 cmH
2
O (Marini 2001). 
Prevention of lung collapse by applying 
PEEP or by using measures aimed at recruit-
ing the lung can theoretically reduce this 
shearing stress and alleviate mechanical 
strain on lung structures (Lachmann 1992). 
e independent contribution of each com-
ponent: baro-, volu- or atelectotrauma, on 
development of VILI is unknown (Pinhu, 
et al. 2003). In the experimental setting, the 
least injurious type of positive pressure ven-
tilation is a combination of low tidal volume 
and high PEEP aiming to avoid overdisten-
sion and repetitive opening and closing of 
alveoli (Dreyfuss and Saumon 1998). In a 
clinical setting, this type of ventilatory strat-
egy has been called the open lung approach 
or lung protective ventilation (Amato, et al. 
1998, Lachmann 1992). Clinical trials on 
mechanical ventilation will be discussed 
later.
e term biotrauma refers to a local and 
systemic inflammatory response associ-
ated with lung injury caused by mechanical 
ventilation (Dreyfuss and Saumon 1998). 
is inflammatory response has been 
tested in several laboratory models as well 
as in clinical settings (Slutsky 1999). ese 
studies have shown marked increases in the 
release of inflammatory mediators such as 
proinflammatory cytokines, TNF-alfa, IL-
6, IL-1beta, and several others (Dreyfuss 
and Saumon 1998). Associated with an 
injurious type of ventilation, the pulmonary 
production of these mediators rises, and 
high concentrations may be detected in 
the bronchoalveolar lavage (BAL) (Ranieri, 
et al. 1999). Increased production of these 
mediators exacerbates pre-existing lung 
damage and results also in spillover into 
the systemic circulation. Systemic effects 
of proinflammatory mediators can initiate 
and cause propagation of a systemic inflam-
matory response leading to detrimental 
effects on several end-organ functions and 
ultimately to multiple organ failure (MOF). 
is pathophysiological pathway is in paral-
lel with the fact that patients with ALI/ARDS 
usually die from MOF and not from hypox-
emia. Hence, it has been postulated that 
mechanical ventilation may be an impor-
tant contributing factor to the development 
of the vicious cycle leading to MOF (Slutsky 
and Tremblay 1998).
2.3.3 Clinical and physiological 
features of ALI
During the initial exudative phase, the clini-
cal presentation of ALI is characterized by 
progressive dyspnoea, tachypnea, hypox-
emia, and worsening of the lung’s mechani-
cal properties. Life-threatening respiratory 
failure usually develops within 24 hours af-
ter the underlying precipitating insult. e 
evolution from this initial exudative phase 
to the proliferative phase ensues within 2 
to 5 days. e proliferative phase is charac-
terised by a hyperdynamic metabolic state 
and signs of multiple organ dysfunction. If 
the patient does not recover, progression 
to the fibroproliferative phase usually takes 
place within 5 to 14 days. During this fibro-
proliferative phase, the lung’s mechanical 
properties worsen further due to fibrosis. 
If resolution and recovery do not occur, 
patients die, usually due to progression of 
MOF, recurrent sepsis, or refractory hypox-
emia (Ware and Matthay 2000).
Accumulation of protein-rich fluid 
into the interstitium leads to increase in 
lung weight. Increased pressure in the 
dependent lung causes alveolar collapse in 
dorsal and posterior parts (Gattinoni, et al. 
1986a). Fluid accumulation is accompanied 
by surfactant dysfunction, which further 
favours atelectasis formation (Nicholas, et 
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al. 1997), which is worsened by absorption 
of oxygen into the pulmonary circulation, 
especially when the inspired gases have a 
high oxygen concentration (Rothen, et al. 
1998). Increased pressure in the abdominal 
cavity may also cause compression tof the 
posterior parts of the lung. Alveolar collapse 
and filling of the airspaces with oedema 
and inflammatory debris causes intrapul-
monary shunting and formation of areas of 
poor ventilation. Alveolar and endothelial 
damage also activates the coagulation cas-
cades, leading to thrombus formation in 
the pulmonary circulation (Welty-Wolf, et 
al. 2002). e inflammatory response alters 
the responses of the pulmonary vasculature, 
and normal hypoxic pulmonary vasocon-
striction is lost.
ese changes cause increased intrapul-
monary shunting and mismatching in venti-
lation-perfusion, and refractory hypoxemia 
thus ensues. Alveolar fluid accumulation 
may block gas diffusion; later fibrotic 
changes worsen this problem. Perfusion 
inequality causes increase in dead space 
ventilation, thus hampering carbon diox-
ide elimination. Development of fibrosis 
leads to a further increase in dead space 
ventilation. Increase in dead space during 
the initial phase of ALI correlates with poor 
outcome (Nuckton, et al. 2002).
Due to fluid accumulation, alveolar col-
lapse, and fibrosis, mechanical properties 
of the lung deteriorate. Airway resistance 
and elastance of the lung and are markedly 
increased. Analysis of respiratory system 
mechanics usually involves reconstruct-
ing a pressure/volume diagram. e total 
respiratory system of an ALI patient has a 
typical sigmoid shape: e initial part of the 
curve is a very gentle slope reflecting low 
compliance at lung volumes below func-
tional residual capacity. e point, where 
the slope of the curve increases has been 
called as the lower inflection point, LIP. e 
slope of the curve is increased after LIP, and 
the compliance is greater. When pressure 
is further increased, a transition to lower 
compliance is observed at a point called the 
upper inflection point, UIP (Stenqvist 2003). 
Figure 2 presents the typical PV curve of one 
ALI patient.
e physiological correspondence and 
clinical utility of mechanical measurements 
in guidance of ventilator treatment has been 
under intense research. e traditional 
interpretation of the PV curve suggests that 
LIP is the critical pressure at which the al-
Figure 2. PV curve for one ALI/ARDS patient by a slow-flow inflation method. 
LIP = Lower inflection point. UIP = Upper inflection point.
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veoli collapse occurs during expiration and 
re-open during inspiration. At the linear 
part of the PV curve, no further recruitment 
occurs, and the decrease in compliance at 
UIP indicates overdistension of the alveoli. 
In accordance with this interpretation, set-
ting the respiratory cycle to occur in the 
linear part between LIP and UIP would be 
the most lung-protective strategy. However, 
because this traditional interpretation of 
PV tracings has several problems, the con-
cept has been challenged (Hickling 2002, 
Stenqvist 2003). It seems obvious that LIP 
does not represent a single point of recruit-
ment, but rather an increased rate of alveo-
lar opening (Stenqvist 2003). Similarly, UIP 
is not a reliable indicator of overdistension 
(Hickling 2002).
A PV curve can be traced by several dif-
ferent methods. Original methods were tru-
ly static measurement with a supersyringe 
(Gattinoni, et al. 1987a) or multiple occlu-
sion with a ventilator (Rossi, et al. 1985). 
ese methods are cumbersome and rarely 
utilized in daily practice. A method using 
single inflation with a ventilator using a 
constant, very slow flow is easier to perform 
in ICU (Lu, et al. 1999). PV curves obtained 
with slow-inflation or semi-static methods 
correlate well with the supersyringe method 
(Lu, et al. 1999). Both static and semi-
static methods require the patient to be 
myorelaxed or heavily sedated. Cessation 
of normal tidal breathing, oxygen uptake 
during measurement, and compression of 
gases may create artefacts (Stenqvist 2003). 
Measurement of lung mechanics during 
tidal breathing (dynamic measurement) 
combined with direct tracheal pressure 
monitoring avoids some of these problems 
and can be used for continuous monitoring 
(Karason, et al. 2001).
e strategy of implementing PV curves 
as a basis for ventilator setting has been 
tested in one randomised clinical trial 
(Amato, et al. 1998), which showed ben-
eficial effects in the group using ventilator 
settings between LIP and UIP as compared 
to the control group with conventional tidal 
and conventional PEEP settings (Amato, et 
al. 1995). Lung mechanics were also used in 
a clinical trial utilizing inflammatory mark-
ers as an endpoint for VALI (Ranieri, et al. 
1999). Concentrations of proinflammatory 
markers in BAL and in the systemic circu-
lation decreased in the treatment group 
in which lung mechanics were measured 
and used in the setting of the ventilator as 
compared to control group values (Ranieri, 
et al. 1999).
2.4 Imaging in ALI
Due to fluid accumulation and airway col-
lapse during the initial phase of ALI, ante-
rior chest x-ray reveals bilateral alveolar 
infiltrates. Asymmetrical patchy consolida-
tions with pleural effusions are typically 
present. An airbronchogram may become 
visible. Alveolar oedema resembles car-
diogenic oedema, but with no signs of left 
atrial hypertension or cardiac enlargement. 
Differential diagnosis of this widespread 
airspace opacification is difficult. Often 
fluid accumulation between hydrostatic 
forces or exudation due to a permeability 
disorder is indistinct, based on chest x-ray 
(Desai and Hansell 1997). As the disease 
progresses, reticular opacities often become 
evident as a sign of increased fibrosis. With 
resolution of ALI, radiological findings ul-
timately disappear (Desai 2002, Desai and 
Hansell 1997).
CT studies have revealed several patho-
physiological features of ALI. One notable 
feature is the reduction in aerated lung vol-
ume and its replacement by fluid and tissue. 
e volume of a functional, aerated lung can 
fall to only 20 to 30 % of its normal volume 
(Gattinoni, et al. 1987a). Another distinct 
feature is the distribution of alterations seen 
on CT. In contrast to that on the anterior 
x-ray, opacifications and loss of gas volume 
are not homogenous in CT scanning, but are 
distributed mostly in the gravity-dependent 
areas of the lung (Gattinoni, et al. 1991).
CT changes in ALI may be defined on 
the basis of morphology. Fleishner Society 
Nomenclature is a widely used definition 
in which CT findings are categorised as 
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ground-glass opacification, consolidation, 
or a reticular pattern (Austin, et al. 1996). 
Pathophysiologically, ground-glass opaci-
fication represents an active inflammatory 
process in the interstitium and alveoli, with 
alveoli incompletely filled with oedema 
fluid, cellular debris, and inflammatory 
cells. Consolidation refers to complete 
or almost complete loss of gas due to the 
complete filling of alveoli or total collapse of 
the lung area. Reticular pattern refers to the 
thickening of interstitial structures due to 
fibrosis, oedema, or inflammation (Austin, 
et al. 1996).
CT findings at different clinical phases of 
ALI are dissimilar. During the early exuda-
tive phase, typical findings include normal 
regions in the anterior, ground glass opaci-
fication in the middle, and consolidation 
in the dorsal parts of the lung (Gattinoni, et 
al. 1986a). is distribution is determined 
largely by gravity on the basis of progressive 
bronchiolar collapse towards the dependent 
zones due to the weight of the overlying 
pulmonary parenchyma (Gattinoni, et al. 
1986a). ere is also a cephalocaudal gradi-
ent; lower lobes are more extensively opaci-
fied than are upper lobes (Malbouisson, et 
al. 2000, Puybasset, et al. 1998). In the later 
phases of ALI, a reticular pattern due to fi-
brosis dominates in CT findings. Densities 
are also more evenly distributed, and usu-
ally resolution of dependent consolidation 
begins. Complications such as bullae and 
extra-alveolar air appear with the pro-
tracted course. Distribution of air cysts and 
bronchiectasises prevail in nondependent 
areas (Treggiari, et al. 2002). After the acute 
phase, fibrotic changes occur in the lung 
parenchyma. e predominantly ventral 
distribution of these changes indicates that 
they may be related to VALI rather than to 
the inflammatory process itself (Nobauer-
Huhmann, et al. 2001). In a long term fol-
low-up, fibrosis also occurs, mainly in the 
anterior portion (Desai, et al. 1999). 
e CT appearance of ALI depends on 
the type of lung injury. A direct insult results 
in densities which are more asymmetric, 
with both dense parenchymal opacifica-
tions and ground glass opacifications. 
In an indirect insult, CT scanning shows 
more symmetric dorsal consolidations and 
ground glass opacifications (Goodman, 
et al. 1999). A French study provides two 
opposite radiological presentations, cor-
responding to different lung morphologies 
(Rouby, et al. 2003a). In patients with focal 
CT attenuations, frontal chest radiography 
generally shows bilateral opacities in the 
lower quadrants; these may remain nor-
mal, particularly when the lower lobes are 
entirely atelectatic. In patients with diffuse 
CT attenuations, the typical radiological 
presentation is “white lung” (Rouby, et al. 
2003a). However, in these studies no cor-
relation existed with type of lung injury 
(Puybasset, et al. 2000). 
is distinction between focal versus 
diffuse loss of aeration has been suggested 
as a guide in the selection of optimal PEEP 
level (Rouby, et al. 2002). In an earlier study, 
CT alterations in the direct injury subgroup 
showed a more homogenous distribution, 
and there was more overlap between mor-
phological findings (Rouby, et al. 2000); in 
that study, the pattern of lung morphol-
ogy correlated with prognosis (Rouby, et al. 
2000).
CT enables the determination of tissue 
density in a given voxel. Tissue CT densi-
ties called Hounsfield units (HU), range 
from  – 1000 HU (gas) to 1000 HU (bone). 
Water has a HU value of 0. Most investiga-
tors studying ALI have used a categorisa-
tion into lung that are nonaerated (tissue 
absorption between 0 and  – 100 HU), poorly 
aerated ( – 100 to  – 500 HU), normally aer-
ated ( – 500 to  – 900 HU), and hyperinflated 
( – 900 to  – 1000 HU) (Gattinoni, et al. 
2001a). In a given region of interest (ROI), 
the distribution of voxels by the CT number 
frequency can be displayed. is technique 
makes it possible to measure the amount 
of gas within the lungs, the amount of lung 
tissue, and the relation between tissue mass 
and volume (Gattinoni, et al. 2001a). 
e CT densitometric technique allows 
investigation of the pathophysiology of 
ARDS and especially the effects of different 
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treatment modalities. ese measurements 
have correlated with several physiologi-
cal variables in several studies. Extent of 
nonaerated tissue has correlated well with 
pulmonary shunt fraction and hypoxemia 
(Gattinoni, et al. 1988, Goodman, et al. 1999, 
Pelosi, et al. 2001). Respiratory compliance 
correlates with the amount of normally aer-
ated lung (Gattinoni, et al. 1987b). e con-
cept of “baby lung” means that decrease in 
compliance is not due to rigidity of the lung, 
but the small volume of normally aerated 
lung (Gattinoni, et al. 1987a). Quantitative 
analysis of CT served in investigation of 
the effects of PEEP (Gattinoni, et al. 1986a), 
body position (Gattinoni, et al. 1991), re-
cruitment manoeuvres (Bugedo, et al. 2003, 
Lim, et al. 2003b), and ventilatory mode 
(Prella, et al. 2002).
Most CT studies in ALI/ARDS patients 
have involved only a few CT slices. Earlier, 
slow scan acquisition , and even at present 
exposure to radiation have limited the num-
ber of slices to be performed, especially in 
studies requiring repeated scans (Brochard 
2001). Recently, a French group has devel-
oped a new technique based on multide-
tector helical scanners (Malbouisson, et 
al. 2001b, Puybasset, et al. 1998), allowing 
the whole lung to be scanned within 3 to 8 
seconds, providing 1.5 mm slices that en-
able reconstruction of the whole lung. By 
manually outlining each section and with 
the aid of special software (Lungview ®), this 
system allows volumetric measurement 
of overinflated, normally aerated, poorly 
aerated, and nonaerated lungs. In addi-
tion, lung recruitment can be measured as 
the amount of gas that penetrates poorly 
aerated and nonaerated lung regions after 
ventilatory intervention (Malbouisson, et al. 
2001b, Rouby, et al. 2003a). e method is 
laborious and is still considered experimen-
tal. Clinical studies utilising it are still few.
2.5 Pharmacological 
treatment in ALI
2.5.1 Pharmacological 
treatment options 
Several pharmacological interventions 
have been tested in the treatment of ALI. 
Proposed therapies include anti-endotoxin 
immunotherapy, cyclo-oxygenase inhibi-
tors, antagonists of pro-inflammatory cy-
tokines, platelet-activating factor inhibitors 
and receptor antagonists, pentoxifylline, 
lipid mediators, several antioxidants, an-
tiproteases, anti-adhesion molecules, and 
surfactant replacement therapy (Artigas, et 
al. 1998). For most of these approaches, the 
evidence is from experimental settings and 
from small-scale physiological trials. A few 
of these proposed pharmaco-therapies have 
entered phase III clinical trials, but unfortu-
nately with negative results. None among 
these therapies is recommended outside 
investigational use at present.
Besides these therapies are inhaled va-
sodilators. Inhaled nitric oxide in partcular 
has been investigated. A universal patho-
physiological finding in ALI is elevated 
pulmonary resistance. Inhaled NO may 
selectively reduce pulmonary artery pres-
sure and improve oxygenation (Rossaint, et 
al. 1993), and several studies have tested the 
possible outcome benefit of inhaled NO, all 
with negative results (Dellinger, et al. 1998), 
meaning that, neither can inhaled NO be 
recommended as a standard therapy for 
ALI. 
2.5.2 Glucocorticosteroids in ALI
Glucocorticosteroids are at present the 
most widely used immunomodulative drug 
therapy (Tasaka, et al. 2002). By binding to 
cytoplastic glucocorticoid receptors, they 
exert broad inhibitory effects on cytokine 
transcription factors and production of pro-
inflammatory cytokines (ompson 2003). 
Glucocorticosteroids may also block cyto-
kine receptors and antagonize cytokine-
mediated activation of transcription factors. 
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Fibroproliferative response has been shown 
to be modulated by the mediators tumor 
necrosis factor alfa, interleucin-1 and -8, 
and tumor growth factor (Luce 2002). By 
reducing the effects of these mediators, 
steroids may interfere with the fibropro-
liferative process (Meduri, et al. 1994). 
Glucocorticosteroids may also prevent 
collagen deposition and increase collagen 
breakdown in several fibrotic diseases.
Due to their broad anti-inflammatory 
properties, glucocorticosteroids have been 
assumed to have a potential benefit in the 
treatment and prevention of ALI/ARDS. 
Administration of a short course of large 
doses of glucocorticosteroids in the early 
phase of ARDS or to septic patients at high 
risk for ARDS was tested in several large 
scale multicenter trials (Luce, et al. 1988, 
Bernard, et al. 1987, Bone 1989). Two meta-
analyses concluded that this concept is 
not beneficial for ARDS patients in terms 
of mortality or reversal of ARDS, and that 
glucocorticosteroids lead to an increased 
number of nosocomial infections (Cronin, 
et al. 1995, Lefering and Neugebauer 1995). 
In sepsis and septic shock, early treatment 
with anti-inflammatory doses of steroids 
may even worsen outcome (Cronin, et al. 
1995, Lefering and Neugebauer 1995).
Increased understanding of the patho-
genesis of ALI and regulation of the host-de-
fence response the during fibroproliferative 
phase of ALI has created a new interest in 
testing the effects of glucocorticosteroids 
in the late phase of ALI/ARDS (Meduri 
2002). A fibroproliferative host response is 
the lungs’ stereotypical reaction to tissue 
injury (Meduri, et al. 1995a). Alveolar and 
epithelial cells are replaced by mesen-
chymial cells, which produce collagen, col-
lagen precursors, and extracellular matrix. 
As a consequence, alveolar and interstitial 
scarring, capillary obliteration, and distor-
tion of lung architecture occur. As a marker 
of collagen accumulation, the procollagen 
aminoterminal propolypeptides type I and 
III are observed in BAL and the systemic cir-
culation (Meduri 1996). Severity of fibrosis 
and mortality correlate with levels of these 
markers in BAL and the systemic circulation 
(Clark, et al. 1995). Although the cause and 
exact mechanism regulating the develop-
ment of fibrosis are not fully understood, 
several anti-inflammatory cytokines are 
known to be necessary to terminate this 
response (Meduri 1996). Clinical manifesta-
tions of fibroproliferation are diverse, and 
differential diagnosis from the pneumonia 
and extrapulmonary infection is very dif-
ficult. Clinical findings of fibroproliferation 
suggested in various studies are sum-
marised in Table 4.
e response of the biological markers 
of fibroproliferation to corticosteroid treat-
ment has been investiged in several studies 
by Meduri et al., who found that prolonged 
corticosteroid treatment was associated 
with rapid decrease in the procollagen ami-
noterminals propolypeptides type I and III, 
and these effects were parallel to clinical 
benefits (Meduri, et al. 1998b).
is theoretical background and clinical 
experience suggest that moderate-dose 
glucocorticoid treatment during the late 
phase of ALI may be beneficial (Biffl, et 
Table 4. Clinical manifestations of the proliferative phase of ALI.
 Fever > 38.8 ºC 
 Leucocytosis > 10 x 103/l
 Diffuse alveolar or interstitial infiltrates
 Fibrotic changes in CT or x-ray
 Increased dead space ventilation
 Neutrophila in BAL
 Positive clinical response to glucocorticosteroids
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al. 1995, Hooper and Kearl 1990, Keel, et 
al. 1998). e first reports were anecdotal 
case studies, but some of these were later 
expanded to larger case series with histori-
cal or concurrent controls. ese studies 
consistently showed improvement in lung 
function and reduction in associated or-
gan dysfunction. In addition, investigators 
reported lower mortality than for historical 
controls, a shortened use of mechanical 
ventilation, and a briefer ICU stay (Biffl, et 
al. 1995, Hooper and Kearl 1990, Keel, et 
al. 1998). Meduri et al have conducted the 
only prospective study on late steroids in 
ARDS. ey included patients with LIS of 
> 2.5 and mechanical ventilation for 7 days. 
Methylprednisolone 2 mg/kg/day in four 
doses was given to the intervention group. 
e study protocol allowed crossover from 
control arm to intervention arm when no 
improvement was observed after 10 days of 
inclusion trial. Four patients were crossed 
over, leaving only 4 in the control group 
(Meduri, et al. 1998a). e study was ter-
minated after 24 randomised patients, due 
to significant reduction in ICU mortality in 
the steroid group. is study has recieved 
criticism, but the results have raised interest 
in the late-steroid concept in ARDS (Brun-
Buisson and Brochard 1998).
2.6 Ventilatory treatment of ALI
2.6.1 Lung-protective ventilation
e most appropriate method of mechani-
cal ventilation and its physiological targets 
have been a subject for debate since the 
description of ALI/ARDS (Moloney and 
Griffiths 2004). Classically, the aim has been 
the normalisation of arterial oxygen and 
carbon dioxide partial pressures. To achieve 
these targets in ALI patients with increased 
dead space, tidal volumes between 12 to 15 
ml/kg have been conventionally used (Tobin 
1994). is is considerably higher than the 
normal resting tidal volume for humans or 
for a wide variety of mammals (Tenney SM 
1963). Concerns about ventilator-induced 
lung injury have led to development of 
ventilatory strategies aimed at avoiding 
the increased mechanical stress which can 
cause further injury to the lungs. e first 
reports were case series and non-controlled 
cohorts, which showed benefit from a gen-
tler ventilatory strategy (Gentilello, et al. 
1995, Hickling, et al. 1994, Lewandowski, 
et al. 1995). ese reports and experimental 
evidence led to formation of a consensus 
statement on ventilatory treatment by the 
American European Consensus Conference 
in 1998 (Artigas, et al. 1998). On the basis of 
expert opinion, this statement suggests that 
airway plateau pressure should be limited to 
below 25 to 30 cmH₂O; no strict values for 
tidal volumes or guidelines for PEEP setting 
were recommended (Artigas, et al. 1998). 
Although vague, the term “lung protective 
ventilation” was advocated by several au-
thors (Amato, et al. 1995). e elements of 
lung-protective ventilation are limitation of 
tidal volume or transpulmonary pressure or 
both. is usually leads to limitation of car-
bon dioxide elimination which is accompa-
nied by hypercarbia, often referred to “per-
missive hypercapnia” (Hickling, et al. 1994). 
To reduce pulmonary collapse, the use of 
high PEEP or recruitment manoeuvres or 
both are usually emphasised as an essential 
part of lung protection. Sometimes this type 
of strategy has been called the open lung 
approach (Lachmann 1992). 
e lung protective strategies have been 
tested in five randomised controlled tri-
als (Amato, et al. 1998, Anonymous 2000, 
Brochard, et al. 1998, Brower, et al. 1999, 
Stewart, et al. 1998). Each of these stud-
ies has used reduced tidal volumes as 
compared to those of the control group, 
but volumes and distending transalveolar 
pressures in both treatment and control 
groups have varied. Permissive hypercapnia 
was allowed in some studies, while others 
tried to maintain normocapnia also in the 
treatment group. e essential difference in 
ventilatory protocols between these studies 
was in the setting of PEEP. e Amato study 
used titration of PEEP based on lung me-
chanical measurement (Amato, et al. 1998), 
while other studies chose a similar protocol 
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for PEEP in both groups. Interpretation of 
the results is difficult also because of differ-
ences in study design. Pooled absolute risk 
reduction for mortality during follow-up in 
these studies was 6 % (95 % CI 1 – 12). In the 
largest trial, the secondary end-point was 
ventilator-free days (Anonymous 2000). 
e difference in means for VFD was 2 days 
with a 0.5 to 3.5 95 % confidence interval. A 
summary of these studies is presented in 
Table 6.
Based on these studies, several meta-
analyses and clinical guidelines have been 
presented (Eichacker, et al. 2002, Petrucci 
and Iacovelli 2003). Definitive answers for 
many issues are still open, and the Cochrane 
Review grades the value of low tidal volume 
as B (Petrucci and Iacovelli 2003). e issue 
of PEEP setting is even more open. A large-
scale trial by the ARDSnet collaboration 
tested the use of systematically higher PEEP. 
Because preliminary results indicated that 
this approach is not beneficial, the study 
was discontinued prematurely. Mortality 
was rate was low (24.9 % vs 27.5 %) in 
both treatment groups with no difference 
whether lower or higher PEEP levels were 
used (Brower, et al. 2004). No firm recom-
mendations conserning the setting of PEEP 
are stated in recent guidelines (Dellinger, et 
al. 2004). 
2.6.2 Ventilatory treatment options 
Several modifications of mechanical ven-
tilation have been developed and brought 
into clinical use (Tobin 1994). Few of 
these have been tested in clinical trials to 
evaluate their impact on outcome in ALI 
(Räsänen and Downs 1991). Delivery and 
setting of the inspiratory waveform profile 
is one aspect of mechanical ventilation. 
Volume-cycled, constant-flow ventilation 
has been compared to pressure-controlled 
ventilation in one randomised trial: In this 
multicenter study, 79 ARDS patients were 
randomly assigned to be ventilated with 
either the pressure-controlled or volume-
controlled mode. In both instances, inspira-
tory plateau pressure was limited to below 
35 cm H₂O. Patients with volume control 
had both a significantly higher in-hospital 
mortality rate (78 % vs. 51 %) and a higher 
number of extrapulmonary organ failures. 
However, multivariate analysis suggested 
that the outcome was unrelated to ventila-
Table 6. Prospective studies investigating protective ventilatory strategies. 
(Amato, et al. 
1998)
(Brochard, et 
al. 1998)
(Stewart, et al. 
1998)
(Brower, et al. 
1999)
NIH 
(Anonymous 
2000)
Number of patients 53 116 120 52 861
Tidal volume in control 
group 12 ml/kg 10.3 ml/kg 10.7 ml/kg 10.5 ml/kg
12 ml/ideal 
body weight
Tidal volume in inter-
vention group < 6 ml/kg 7.1 ml/kg 7 ml/kg 7.5 ml/kg
6 ml/ideal 
body weight
PEEP in control group 8.7 cmH2O 10.7 cmH2O 7.2 cmH2O 8.2 cmH2O 8.6 cmH2O
PEEP in intervention 
group 16.4 cmH2O 10.7 cmH2O 8.6 cmH2O 9.5 cmH2O 9.4 cmH2O
Mortality in control 
group 71 % 47 % 46 % 47 % 39 %
Mortality in interven-
tion group 45 % 38 % 50 % 50 % 31 %
ARR %
95 % CI
26
0 – 52
 – 8.6
 – 9 – 27
3.3
 – 15 – 21
 – 3.8
 – 23 – 31
8.8
2 – 15
ARR = Absolute risk reduction; 95 % CI = 95 % confidence interval.
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tory mode (Esteban, et al. 2000a). Smaller 
trials comparing volume-controlled to 
pressure controlled ventilation have dem-
onstrated only minor differences between 
the modes when settings were comparable 
(Lessard, et al. 1994, Prella, et al. 2002).
Adjustment of the inspiratory-expira-
tory time-ratio by extending inspiratory 
time is one modification of conventional 
ventilation. It is usually referred as inverse 
ratio ventilation (IRV) (Marcy and Marini 
1991). By extending the inspiratory time, 
peak airway pressure can be reduced, and 
at the same time mean airway pressure 
is increased (Marcy and Marini 1991). 
Increase in mean airway pressure is related 
to improvement of oxygenation in some 
studies (Wang and Wei 2002, Zavala, et al. 
1998), while most studies show no benefit 
(Lessard, et al. 1994, Mercat, et al. 1997). 
e short time allowed for expiration cre-
ates the potential for incomplete expira-
tion before the next inspiration, a situation 
referred to as air trapping or development 
of intrinsic PEEP. is may lead to hyperin-
flation, barotraumas, and heamodynamic 
compromise (Lessard, et al. 1994, Ludwigs, 
et al. 1997, Valta and Takala 1993). In a 
physiological study by Valta et al (1993) 
the effect of reduced expiratory time on 
end-expiratory lung volume and pressure 
during volume-controlled IRV was similar 
to the use of PEEP (Valta and Takala 1993). 
In a long-term follow-up with CT scanning, 
the use of IRV was related to an increased 
amount of reticular, fibrotic changes in 
anterior parts of the lung among survivors 
of ARDS (Desai, et al. 1999). No prospective 
study has compared IRV to the conventional 
mode in order to test its implications for rel-
evant clinical outcome measures.
High frequency ventilation (HFV) refers 
to techniques employing much higher 
breathing frequencies and much smaller 
tidal volumes than those of conventional 
mechanical ventilation. Since its first de-
scription in 1972, it has been used mainly 
in paediatric patients, but evidence of its 
benefits is still controversial (Henderson-
Smart, et al. 2003). eoretically, a venti-
latory strategy which combines very low 
tidal volume and alveolar excursion with 
high mean airway pressure and good lung 
recruitment may be ideal to avoid VILI. 
e clinical benefit of HFV has been tested 
in one randomised clinical trial involving 
patients with severe ARDS (Derdak, et al. 
2002). is trial showed a trend towards an 
improved outcome associated with early 
use of HFV, but it was underpowered to 
show any benefit for mortality (Derdak, et 
al. 2002).
2.6.3 Partial ventilatory modes 
Interaction between ventilator and patient 
is another aspect of ventilatory treatment of 
ALI. Traditionally, mechanical ventilation 
has been applied with full control of alveo-
lar ventilation by ventilator in order to com-
pletely unload the patient from the work 
of breathing. When improvement of gas 
exchange and mechanical disturbance al-
lowes, partial ventilatory modes are able to 
facilitate weaning from respiratory support. 
Several partial ventilatory modes have been 
developed to employ various techniques to 
combine the patient’s spontaneous activity 
and the ventilator´s mechanical assistance. 
Differences between modes are subtle with 
clinical benefits still unproven (Räsänen 
and Downs 1991).
Interaction between spontaneous 
breathing and mechanical ventilation 
can serve to categorize partial ventilatory 
techniques (Putensen, et al. 2002). e first 
group consists of modes where every spon-
taneous inspiratory effort is augmented by 
a response from the ventilator. Assist-con-
trolled ventilation (ACV), pressure support 
ventilation (PS), and proportional assist 
ventilation (PAV) belong to this category. 
e second group comprises types in which 
minute ventilation is modulated by addition 
of non-assisted inspirations; intermittent 
mandatory ventilation (IMV) and its modi-
fication, synchronised intermittent manda-
tory ventilation (SIMV), are examples. e 
third category comprises ventilatory modes 
in which unrestricted and unsupported 
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spontaneous breathing is possible at any 
phase of the mechanical ventilatory cycle, 
and switching between two airway pres-
sures provides mechanical part of alveolar 
ventilation. Airway pressure release ventila-
tion (APRV) and biphasic positive airway 
pressure ventilation (BIPAP) represent this 
category. e fourth category comprises 
various hybrid modes combining elements 
from the other categories, with SIMV with 
PS one example (Putensen, et al. 2002).
Preserving spontaneous breathing efforts 
during mechanical ventilation offers several 
potential physiological benefits. Improved 
gas exchange has resulted from several 
experimental and clinical studies of the 
effects of maintained spontaneous breath-
ing (Hörmann, et al. 1997, Putensen, et al. 
1995a, b, Sydow, et al. 1994, Valentine, et al. 
1991). One mechanism suggested to lead to 
these benefits is a more favourable distribu-
tion of spontaneous ventilation as compared 
to controlled breaths. During active inspira-
tory effort, the posterior muscular part of 
the diaphragm contracts more than does 
the anterior tendon plate (Froese and Bryan 
1974). As the posterior, dependent parts of 
the lung are well perfused, improvement 
occurs in the ventilation-perfusion ratio. If 
diaphragmatic tone is abolished by neuro-
muscular blockade, the changes are even 
more pronounced when the diaphragm is 
moved cranially by the pressure of the intra-
abdominal organs (Tokics, et al. 1996). With 
totally controlled ventilation, posterior and 
juxtadiaphragmatic lung areas develop atel-
ectasis and consolidation even with normal 
lungs (Froese and Bryan 1974, Tokics, et al. 
1996); and atelectasis formation with ALI 
is pronounced (Gattinoni, et al. 1986b). 
If diaphragmatic contractions are main-
tained, the lung collapse may be counter-
balanced. is was shown by Hedenstierna 
et al in study during which the phrenic 
nerve was stimulated unilaterally during 
anaesthesia. Atelectasis size in CT scanning 
on the stimulated side was almost abol-
ished (Hedenstierna, et al. 1994). It seems 
that maintained spontaneous breathing 
can also recruit a previously collapsed lung. 
One surrogate of this is the improvement of 
the V/Q ratio, when controlled ventilation is 
switched to a ventilatory mode, where spon-
taneous breathing is possible (Wrigge, et al. 
2003, Putensen, et al. 1999). e process of 
recruitment takes time, as shown in a cross-
over study in ARDS patients by Sydow et al 
(1994). Decrease in shunting and improve-
ment of oxygenation was observed after 
several hours when volume-controlled IRV 
was changed to APRV with unsupported 
spontaneous breathing (Sydow, et al. 1994). 
To gain these benefits, only 10 to 30 % of the 
minute ventilation is necessary, and spon-
taneous tidal volumes may be as small as 70 
to 150 ml (Hörmann, et al. 1997).
Due to cyclic reduction in intrathoracic 
pressure resulting from spontaneous breath-
ing, partial ventilatory modes have profound 
effects on the cardiovascular system. During 
unsupported spontaneous inspiration, 
venous return is enhanced and filling of 
the heart is increased. is has been shown 
to contribute to enhanced cardiac output, 
which together with improved oxygenation 
results in increased oxygen delivery; when 
a moderate amount of spontaneous breath-
ing is maintained, oxygen consumption due 
to activity of the respiratory muscles is un-
changed (Putensen, et al. 1999). In addition, 
spontaneous breathing has been associated 
with better renal perfusion when compared 
to total mechanical control of ventilation 
(Hering, et al. 2002). In an experimental set-
ting, spontaneous breathing was associated 
also with improved intestinal blood flow 
– especially in the mucosal and submucosal 
layer (Hering, et al. 2003).
Physiological actions of different par-
tial ventilatory modes are not identical. 
Interaction between ventilator and the pa-
tient’s effort is a critical issue. In ventilatory 
modes where each inspiratory effort is as-
sisted, as with PS or ACV, comparable effects 
on gas exchange and haemodynamics are 
compared to those in the totally controlled 
ventilatory mode. Only with a ventilatory 
mode in which unsupported spontaneous 
breathing is possible, superimposed on me-
chanical ventilation, has it been shown that 
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these benefits can be achieved (Putensen, et 
al. 1994b, 1997).
Various forms of intermittent mandatory 
ventilation techniques constitute nowadays 
the most widely used partial ventilatory 
mode (Esteban, et al. 2000b). e principle 
of IMV was introduced to clinical practice 
by Downs et al (1973). Later, developed 
synchronisation was presented by Shapiro 
et al (1976). SIMV was originally presented 
to facilitate weaning, but it has also been 
used widely as a primary ventilatory mode. 
Benefits of SIMV as a weaning mode are 
controversial, and most studies show that 
SIMV may have even a tendency to prolong 
the weaning phase (Butler, et al. 1999). In 
no studies has SIMV been compared to 
controlled ventilation or to partial ventila-
tory modes as a primary ventilatory mode. 
However, SIMV with PS is the ventilatory 
mode most commonly used currently, e.g., 
in the Nordic countries (Karason, et al. 
2002), in this survey, particularly pressure-
regulated ventilator modes were used for 
86 % of the patients.
With a modern ventilator, SIMV is com-
monly used together with pressure support 
ventilation. With PS, every inspiratory effort 
is augmented with a preset pressure, which 
is maintained until switchover to expiration 
takes place. is cycling off is governed by 
inspiratory flow. Usually decay of inspira-
tory flow down to 25 % of peak inspiratory 
flow is used as the cycling-off criterion. PS 
unloads respiratory muscles and reduces 
the work of breathing, however, with pa-
tient-ventilator dyssyncrony commonly 
observed, which can paradoxically increase 
the work of breathing. In some studies, 
PS has improved gas exchange, but most 
studies show no benefit when compared to 
controlled ventilation (Cereda, et al. 2000, 
Dembinski, et al. 2002). PS has been tested 
in an observational study as a primary 
mode in ALI/ARDS (Cereda, et al. 2000), but 
institution of PS was not associated with any 
significant changes in gas exchange or in 
haemodynamics.
2.6.4 Airway pressure 
release ventilation
Airway pressure release ventilation is a par-
tial ventilatory mode which was initially de-
veloped to augment alveolar ventilation as 
an adjunct to spontaneous breathing with 
continous positive airway pressure (CPAP) 
(Downs and Stock 1987). e concept is that 
the patient is breathing spontaneously on 
CPAP, which is titrated in order to optimise 
recruitment of alveoli and to increase FRC 
to a level where oxygenation and the work of 
breathing are acceptable (Stock, et al. 1987). 
From this pressure level, a rapid decreases 
to a lower pressure level (airway pressure 
release) allows expiratory flow, and re-es-
tablishment of higher airway pressure ree-
inflates the lungs with fresh inspiratory gas 
(Downs and Stock 1987). e timing of this 
airway pressure release as well as timing of 
a higher pressure level can be set separately. 
Time-setting for airway pressure release is 
adjusted to ensure enough time for expira-
tory flow and reduction of lung volume, en-
abling an adequate tidal volume during re-
establishment of higher airway pressure. On 
the other hand, excessive release time pro-
motes alveolar collapse during lower alveo-
lar pressure. Commonly, the time reserved 
for airway pressure release is between 0.8 
and 2 seconds. If mechanical augmentation 
is between 8 and 16 times per minute, the 
time for higher airway pressure is between 2 
and 5 seconds. With this type of setting, the 
patient’s spontaneous efforts occur at the 
higher pressure. Expiratory flow is usually 
minimal after re-establishment of higher 
pressure, and tidal volumes of spontane-
ous inspiratory efforts are usually relatively 
small. However, as alveoli and conducting 
airways are filled with inspiratory fresh gas 
after airway release, this ventilation is not 
dead space ventilation, and these small 
tidal volumes augment alveolar ventilation 
(Hörmann, et al. 1997).
Figure 3 presents airway pressure and 
flow tracings during APRV.
In the original descriptions, APRV was 
provided by a high-flow CPAP circuit 
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equipped with a fast-action release valve 
(Downs and Stock 1987). With airway pres-
sure, the release circuit can be opened to 
the ambient air or to the CPAP valve with 
lower pressure threshold. With modern 
ventilators, APRV can be arranged by a 
microprocessor-controlled fast-acting expi-
ratory valve and gas source, which can pro-
vide an open system enabling spontaneous 
breathing any time during the respiratory 
cycle (Hörmann, et al. 1994). With a micro-
processor-driven ventilator, various ways 
have been developed to synchronise airway 
pressure shifts and spontaneous breathing 
efforts. e physiological impact of this 
property is not fully understood (Putensen, 
et al. 1994a). Considerable confusion is 
caused by the commercial trade names of 
various ventilator manufacturers.
Most of the clinical studies investigat-
ing physiological variables for APRV as 
compared to other ventilatory forms have 
been short-term studies (Cane, et al. 1991, 
Hörmann, et al. 1997, Putensen 1997, 
Putensen, et al. 1999, Valentine, et al. 
1991). One prospective observational study 
showed APRV to be a feasible alternative 
to conventional mechanical ventilation in 
patients with acute lung injury of mild to 
moderate severity (Räsänen, et al. 1991). 
In a crossover setting and with a longer 
intervention period than in previous trials, 
Sydow et al (1994) compared APRV to vol-
ume-controlled IRV, concluding that APRV 
was associated with progressive alveolar 
recruitment over time during the 24-hour 
intervention period (Sydow, et al. 1994). 
APRV has also been associated in prospec-
tive observational studies with decreased 
need for sedation and vasoactive drugs 
(Kaplan, et al. 2001, Sydow, et al. 1994). 
Two prospective, non-RCT studies have 
compared APRV to controlled ventilation. 
Kiehl et al (1996) showed in severely ill, 
leukopenic patients that acceptable oxygen-
ation was achieved at lower airway pressures 
with APRV than with volume-controlled 
ventilation, but due to small size (n = 20) and 
high overall mortality, no conclusions as to 
outcome could be drawn. Putensen´s group 
investigated multiple trauma patients at risk 
for ALI in a strictly designed RCT, showing 
that maintaining spontaneous breath-
ing during APRV requires less sedation 
and improves cardiopulmonary function, 
presumably by recruiting nonventilated 
lung units. ey could also show a shorter 
duration of ventilatory support and ICU 
stay in the group receiving APRV as a pri-
mary ventilatory mode. e control group 
received ventilation at comparable settings, 
but they were myorelaxed in order to abol-
ish spontaneous breathing (Putensen, et al. 
2001). No randomised, controlled study of 
ALI/ARDS patients has compared APRV to 
other ventilatory modes.
Figure 3. Airway pressure and flow tracing during APRV.
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2.7 e use of prone 
positioning in ALI
e rationale for treating ALI/ARDS pa-
tients in the prone position (PP) rises from 
several observations. Bryan et al (1974) 
first suggested that in patients with bilat-
eral lung disease prone positioning could 
redistribute ventilation to the hypoventi-
lated dorsal part of the lung (Bryan 1974). 
e clinical benefit for oxygenation has 
since been described in numerous studies 
(Douglas, et al. 1977, Gattinoni, et al. 1991, 
Langer, et al. 1988) which have consistently 
shown oxygenation to improve markedly in 
60 to 70 % of ALI patients when the patient 
is turned prone (Pelosi, et al. 2002). Clinical 
studies have also shown that improvement 
in oxygenation occurs very rapidly and that 
degree of improvement is unrelated to the 
extent to which gas exchange is impaired. 
Improvement can persist is some but not 
in all patients when they are returned to 
the supine position. Response to being 
prone may vary depending on the course 
of the disease and the underlying aetiology 
(Messerole, et al. 2002).
Several pathophysiological mechanisms 
may account for the effects of prone po-
sitioning (Messerole, et al. 2002). In the 
supine position and during controlled 
ventilation the tendency is for dorsal al-
veolar collapse and hypoventilation. Lung 
perfusion has, however, a predilection 
for dependent lung areas, so decreased 
regional ventilation results in mismatching 
of ventilation and perfusion and thus in 
intrapulmonary shunting. Conversely, the 
nondependent part of the lung will be bet-
ter ventilated but less perfused, leading to 
an increase in alveolar dead space (Pappert, 
et al. 1994). When the patient is turned 
prone, pleural pressure is more uniform 
as a result of the change in diaphragmatic 
shape (Krayer, et al. 1989) and in postural 
differences in chest wall mechanics. One 
claimed physiological phenomenon in the 
prone position is that the lungs fit into the 
thorax with less distortion from the heart, 
mediastinum, and diaphragm (Albert and 
Hubmayr 2000, Malbouisson, et al. 2000). 
As ventilation is distributed more uniformly 
and distribution of perfusion remains 
fairly intact, ventilation and perfusion more 
closely match, and oxygenation improves 
(Mure, et al. 2000). Reversal of dorsal hy-
poventilation also results in an increase in 
functional residual capacity and hence in 
overall recruitment of alveoli (Guerin, et al. 
1999). Furthermore, the effects of recruit-
ment manoeuvres are both increased and 
prolonged (Cakar, et al. 2000, Tugrul, et 
al. 2003). PP may allow also more efficient 
drainage of secretions from peripheral air-
ways. By enhancing recruitment and by im-
proving regional ventilation, PP may reduce 
both overdistension and repeated intratidal 
collapse of the lung during mechanical ven-
tilation. In an experimental setting, there is 
evidence that PP may protect the lung from 
VILI (Broccard, et al. 1997), although, body 
position has not affected the location of VILI 
(Nishimura, et al. 2000).
e possible benefit to clinical outcome 
of a strategy using PP has been tested in 
one published clinical trial (Gattinoni, et 
al. 2001b). e two trials available thus far 
have appeared only as abstracts. An Italian 
multicenter trial used PP once a day for 
6-hour episodes if the PaO₂/FiO₂ ratio 
dropped below 200 mmHg. In this study, 
the increase in ratio of partial pressure 
of arterial oxygen to fraction of inspired 
oxygen, as measured each morning while 
patients were supine, was greater in the 
prone group. e relative risk of death in the 
prone group vs. the supine group was 0.84 at 
the end of the 10-day study period, but this 
difference in mortality was not significant 
(95 % CI, 0.56 to 1.27). However, in post hoc 
analysis, those patients in the quartile of the 
most severely ill showed a reduction in ICU 
mortality (Gattinoni, et al. 2001b). Hence, 
inclusion of patients with minor defects in 
oxygenation might have diluted the effect 
of PP. All these studies used the controlled 
mode of ventilation.
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2.8 Outcome of ALI/ARDS
In the first reported case series of ARDS, 
seven of twelve died (Ashbaugh, et al. 1967). 
e mortality from ARDS/ALI is still high, 
with mortality in case series havarying from 
20 to 89 % (Ullrich, et al. 1999), although 
mortality seems to be declining (Milberg, et 
al. 1995). Some case series report even lower 
mortality rates, but the patient population 
in those studies has been highly selected 
(Ullrich, et al. 1999). In recent cohort-based 
investigations with strict methodology, the 
reported survival rates have ranged from 
34 % (Bersten, et al. 2002) to 42 % (Luhr, et 
al. 1999). Mortality in the very recent large, 
randomised, controlled trials have ranged 
from 25 % (Brower, et al. 2004) to 39.8 % 
(Anonymous 2000). It is said that this is the 
concurrent standard to which future trials 
are to be compared (Levy 2004). 
In most cases, deaths of ARDS/ALI 
patients are not due to respiratory failure. 
Development of multiple organ dysfunction 
and its progression to ultimately untreat-
able multiple organ failure is usually the ul-
timate cause of death. Interestingly, degree 
of hypoxemia or other marker for severity 
of lung injury shows a poor correlation with 
ARDS mortality (Gould, et al. 1997). In the 
early phase of lung injury, the increased 
ratio of dead space ventilation is the only 
marker of lung function which has shown 
good correlation with prognosis of ALI/
ARDS (Nuckton, et al. 2002). Commonly 
used prognostic scoring systems include a 
wide range of clinical variables. Predictive 
models like APACHE II (Knaus, et al. 1985) 
and SAPS II (Le Gall, et al. 1995) can be used 
to describe a patient population and predict 
mortality in large patient groups also with 
ALI/ARDS (Knaus, et al. 1991). e value of 
current scoring systems in estimation of a 
patient’s individual risk of death is low.
Mortality is a very crude measure of 
outcome, even in conditions with high 
mortality like ARDS. Mortality in ARDS is 
attributable to multiple factors including 
underlying illness, specific treatments, and 
general supportive therapy. Inclusion of 
homogenous patient populations in stud-
ies testing any new intervention is difficult. 
For these reasons, surrogate end-points for 
mortality have been advocated such as, 
length of mechanical ventilation, ventilator 
free days, length of ICU-stay and ICU-free 
days (Schoenfeld, et al. 2002, Vincent 2004).
Pulmonary function in ALI/ARDS survi-
vors has been investigated in several studies 
(Cooper, et al. 1999, Herridge, et al. 2003, 
McHugh, et al. 1994) indicating that lung 
mechanics return to normal within one 
year, but gas-exchange abnormalities such 
as decreased diffusion capacity and exercise 
tolerance persist longer (Cooper, et al. 1999, 
McHugh, et al. 1994). Abnormalities seen in 
CT images may even be detectable after one 
year following the ALI episode (Desai, et al. 
1999).
Long-term outcome and quality of life 
has become an important measure of 
critical care outcome (Lee and Hudson 
2001), but large-scale studies focusing on 
the quality of life of ARDS/ALI survivors 
are still few. A Canadian study found that 
survivors of ARDS have considerable limita-
tions in several physiological functions and 
a reduced quality of life in several domains 
of the health survey (Herridge, et al. 2003). 
Neuropsychological tests may also reveal 
deficits, especially in ARDS patients who 
have suffered severe and protracted hypox-
emia (Hopkins, et al. 1999). As compared 
to other critically ill patients, survivors of 
ARDS show a clinically significant reduc-
tion in health-related quality of life that 
appears to be caused exclusively by ARDS 
and its sequelae. Reductions were primarily 
noted in physical functioning and pulmo-
nary function (Davidson, et al. 1999). One 
year after ICU care, the survivors still have 
a lower quality of life than an age-matched 
general population (Pettilä, et al. 2000). 
Psychological sequalae may also occur, 
presenting as posttraumatic stress disorder 
(Schelling, et al. 1998).
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3. AIMS OF THE STUDY
e aim of the present study was to evaluate different modalities of treat-
ment for acute lung injury. Partial ventilation modes as a primary treatment 
strategy throughout the clinical course of ALI and glucocorticosteroid dur-
ing the late phase of ALI were the primary objectives.
e specific objectives were:
1. To test the hypothesis that in ALI patients, primary use of APRV with 
maintained unsupported spontaneous ventilation as compared to SIMV 
with PS
 a. is feasible for ARDS patients (Studies I – III)
 b. increases the number of ventilator-free days (Study II)
 c. improves gas exchange and haemodynamics (Study II)
 d. reduces need for sedative medication (Study II)
2. To investigate the combined effects of APRV and prone positioning on 
gas exchange as compared to SIMV with PS (Studies I and III)
3. To investigate the effects of APRV as compared to SIMV on lung collapse 
as measured with lung CT (Study IV)
4. To determine in patients with primary acute lung injury the effects of 
prolonged methylpredisolone treatment on gas exchange and multiple 
organ dysfunction (Study V)
31 HUCH, Jorvi Hospital Publications • Series A 04/2004 32HUCH, Jorvi Hospital Publications • Series A 04/2004
4. MATERIAL AND METHODS
4.1 Patients
e 89 study patients were treated in the 
Intensive Care Unit (ICU), Division of 
Anesthesia and Intensive Care, Department 
of Surgery, Helsinki University Hospital. 
Study I is a report of one severe ARDS patient 
in whom the feasibility of a combination of 
prone position and APRV was tested for the 
first time. Studies II to IV are reports cover-
ing one population during the years 1998 
to 2000. During the study period, a total of 
1584 ICU patients were treated, and from 
among these 58 ALI patients were included 
in this study. All of these 58, were subjects 
of Study II. Study III was a pre-defined 
subanalysis regarding the effects of prone 
positionining. All those patients for whom 
CT scanning could be done twice during the 
first 7 study days were analysed in Study IV. 
Study V utilized a retrospective cohort of 31 
primary ALI patients during years the 1994 
to 1998. Demographic characteristics are 
presented in Table 7.
4.2 Study design
S I is report presents the clinical 
course of one patient with severe ARDS. 
As a part of the treatment, unsupported 
spontaneous breathing superimposed on 
mechanical ventilation with APRV was uti-
lized and used together with PP.
S II Number of ventilator free-days 
alive (primary endpoint), length of stay in 
Table 7. Demographics of the patients. (Figures are median and interquartile range; for 
Study V mean ± SD are given).
Study II (N = 58) Study III* (N = 33) Study IV* (N = 23)  Study V (N = 31)
APRV SIMV APRV SIMV APRV SIMV Steroid Control
N 30 28 15 18 13 10 16 15
Gender
Female/male
21/9 18/10 4/11 4/14 4/9 1/9 4/12 3/12
Age 50.0(38.5 – 60.5)
44.0
(35.5 – 53.0)
50.0
(37.0 – 60.0)
46.5
(37.2 – 55.3)
48.0
(34.0 – 64.0)
48.0
(40 – 56) 42.4 ± 2.8 44.9 ± 3.7
APACHE II 15(12.5 – 18.0)
14.0
(11.3 – 17.0)
14.0
(11.0 – 16.0)
14.0
(13.0 – 17.3)
14.8
(11.5 – 18.5)
15.2
(13.8 – 17.0) 14.4 ± 1.6 14.8 ± 1.6
SOFA 
(MODS in 
Study V)
9.0
(7.0 – 10.5)
8.5
(8.0 – 9.8)
8.0
(7.0 – 10.0)
9.0
(7.8 – 10.0)
9.5
(8.0 – 10.0)
8.7
(7.0 – 10.0) 7.5 ± 0.7 8.2 ± 1.0
PaO2/FiO2 
ratio at 
inclusion
135
(106 – 195)
150
(130 – 187)
123
(100 – 150)
137
(125 – 173)
158
(104 – 213)
165
(140 – 190) 126 ± 52
107 ± 41
Primary vs 
secondary 
ALI
23/7 22/6 10/5 11/7 9/4 9/1 16/0 15/0
* Studies III and IV are subgroups of Study II.
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the ICU, mortality, use of sedative medica-
tion, gas exchange and haemodynamic data 
were analysed. In this prospective, open, 
controlled study, 58 patients fulfilling the 
AECC criteria for ALI after a structured sta-
bilisation period were enrolled. Exclusion 
criteria were prior mechanical ventilation 
for more than 72 hours, chronic pulmonary 
disorder, neurological cause of respira-
tory failure, contraindication for permissive 
hypercapnia, condition in which full life-
support was not indicated, or having par-
ticipated in any interventional trial of septic 
shock within 30 days. After randomisation, 
patients received either APRV with main-
tained unsupported spontaneous breathing 
or SIMV with pressure support.
S III e effect of ventilatory mode on 
response to prone positioning was inves-
tigated in a prospective, randomised, and 
open study. Of the 58 patients included in 
Study II, the first 45 consecutive patients 
formed the subjects of this study. e prone 
positioning was part of the general protocol 
unless contraindicated. For the 33 patients 
in whom prone positioning was used, the 
first two periods of prone positioning were 
analysed. Gas exchange was measured 
before and at the end of each prone posi-
tioning period. Of these patients, 33 were 
turned prone once and 28 twice. Changes 
in oxygenation were analysed in response to 
the first and second prone episodes 5 h and 
24 h after randomisation and initiation of 
SIMV-PC/PS or APRV, respectively.
S IV e CT densitometric technique 
was used to investigate the extent of lung 
collapse and gas distribution in the lungs 
in patients enrolled in Study II. CT scanning 
was performed before randomisation until 
47 patients were included. In the 23 patients 
who still needed ventilatory support at day 
7, a follow-up CT scan was performed. ese 
patients were the subjects of this study. 
Figure 4 presents flowchart of Studie II~IV.
S V Evaluation of the clinical effects of 
prolonged methylprednisolone treatment 
was done by analysis of a retrospective co-
hort of ARDS patients. e patient records 
of all those mechanically ventilated during 
the study period 1994 to 1998 were evalu-
ated. Criteria for inclusion in the study were: 
mechanical ventilation for acute respiratory 
Figure 4. Flowchart of studies comparing airway pressure release ventilation and 
syncronised intermittent mandatory ventilation.
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failure for more than 10 days, and pulmo-
nary, infectious aetiology of ALI. Exclusion 
criteria were: prior corticosteroid treatment, 
chronic immunosuppression, respiratory 
failure due to neurological disturbance, and 
surgery during the first 10 days in the ICU; 
31 patients fullfilled these criteria. Of these, 
16 patients had received empiric prolonged 
methylprednisolone treatment during late 
phase ALI, and 15 were managed without 
glucocorticosteroids and served as a control 
group.
4.3 Methods
4.3.1 Interventions
S II – IV Attending physicians were 
responsible for ventilator management 
according to a written protocol. In the 
APRV group, the ventilatory mode was ac-
complished with a special module (Bivent, 
Siemens-Elema, Gothenburg, Sweden) at-
tached to the Servo 300 SV ventilator. With 
this module, the ventilator can be set to a 
mode in which unsupported, spontaneous 
breathing is possible throughout the entire 
ventilatory cycle at two airway pressure 
levels. Time periods for each pressure level 
can be set independently. Duration of lower 
pressure was adjusted to allow expiratory 
flow to decay to zero. e duration of the 
higher pressure was adjusted to produce 12 
pressure shifts per minute. e target for the 
patient’s spontaneous breathing frequency 
was 6 to 18 times per minute, with tidal vol-
umes of spontaneous breathing over 10 % 
of the level of mechanical tidal volumes 
considered sufficient. Presence of sponta-
neous breathing was continuously verified 
from the flow and pressure tracings of the 
ventilator display. If spontaneous breath-
ing was not achieved, the level of sedation 
was reduced. If sedation was adequate, the 
frequency of pressure shifts was decreased. 
If spontaneous breathing frequency in-
creased to over 20 per minute, sedation 
was increased and, if needed, mechanical 
frequency increased.
In the control group, patients were ven-
tilated with the pressure controlled SIMV 
mode with pressure support. Rate of man-
datory time-cycled, pressure-controlled 
breaths was set initially to 12 per minute. 
Pressure support of 10 cmH
2
O was used for 
triggered breaths. In pressure-supported 
breaths, inspiratory pressure was main-
tained until inspiratory gas flow decreased 
to 25 % of its peak value. In the SIMV group, 
triggered breaths were not required. If 
frequency of triggered breaths increased to 
over 10 per minute, sedation was increased 
and, if needed, the rate of mandatory 
breaths increased. A summary of ventilator 
strategies following after the randomisation 
are presented in Table 8.
S V During the study period, pro-
longed methylprednisolone treatment was 
an empiric therapy for patients with un-
resolved ALI. e decision on prolonged 
methylprednisolone treatment was based 
on consultation with a specialist in infec-
tious diseases and individual evaluation of 
the patient. Patients with consistently high 
levels of CRP as a sign of sustained inflam-
mation, with progressive respiratory failure 
despite adequate antimicrobial treatment, 
and with no evidence of untreated infec-
tion were considered candidates for pro-
longed methylprednisolone treatment. La-
bile diabetes or gastrointestinal bleeding 
were contraindications for corticosteroids. 
Treatment was with intravenous methyl-
prednisolone (Solu-Medrol, Pharmacia & 
Upjohn, Stockholm, Sweden) initiated at a 
dose of 80 mg in the morning and 40 mg in 
the evening in order to simulate circadian 
variation in the natural hypothalamic-pi-
tuitary-adrenal axis. Based on clinical re-
sponse, the dose was gradually tapered off.
4.3.2 General ventilatory measures 
e physiological targets and basis for the 
main ventilatory settings were as follows: 
Oxygenation goal PaO₂ 8 kPa or more; or 
target for PaCO₂ between 5 and 8 kPa, but 
higher PaCO₂ also allowed, if pH at the same 
time remained over 7.20.
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All patients were ventilated with a Servo 
300 SV (Siemens-Elema, Gothenburg, Swe-
den) ventilator using pressure-controlled 
ventilatory modes. In order to set inspira-
tory pressure and PEEP, the following proto-
col was followed: the pressure-volume (PV) 
curve of the patient’s respiratory system was 
constructed during the stabilization phase 
and thereafter according to the judgement 
of attending clinicians until the weaning 
phase. PV curves were reconstructed dur-
ing transient neuromuscular blockade. For 
the 12 first patients in Study III, the PV curve 
was obtained by applying variable tidal 
volumes and measuring static airway pres-
sures, and for the rest of the patients by us-
ing the slow-flow inflation method (Lu, et al. 
1999). External PEEP was titrated above the 
lower inflection point (LIP) of the PV curve. 
If the LIP was undetectable, PEEP was set to 
10 cmH
2
O. Inspiratory pressure (Pinsp) was 
set to accomplish a tidal volume between 8 
and 10 ml/kg. However, the upper inflection 
point (UIP), if detected from the PV curve, 
was never exceeded. Inspiratory pressure 
was always kept below 35 cmH
2
O.
4.3.3 Prone positioning
Indication for prone positioning for both 
study groups was the same. Oxygenation 
was assessed twice per day, and a PaO₂/FiO₂ 
ratio of less than 200 mmHg was a trigger for 
a change to the prone position. Prone po-
sitioning was accomplished in regular ICU 
beds. e thorax was supported to avoid 
hyperextension of the neck, but no special 
equipment was used. e prone periods 
Table 8. Summary of ventilatory strategies. (Table 1 from study II).
APRV-group SIMV-group
Response to patients effort Unsupported, spontaneous breath-
ing, required 6 to18 per minute 
Pressure support of 10 cmH2O, not 
required
Intitial settings
PEEP Titrated according PV-curve Titrated according PV-curve
Pplat allowed < 35 cmH2O or UIP < 35 cmH2O or UIP
Tidal volume Driving pressure titrated to form 
8 to10 ml/kg tidal volume
Driving pressure titrated to form 
8 to10 ml/kg tidal volume
Set respiratory rate 12 pressure releases/minute 12 SIMV-cycles/minute
Length of inspiratory phase 4 seconds 35 % of the SIMV-cycle
Length of expiratory phase 1 second 65 % of the SIMV-cycle
Measures to achieve oxygen-
ation target (PaO2 > 8 kPa)
FiO2 ↑ Increase up to 1.0 Increase up to 1.0
IRV ↑ Not used IRV ad 2:1
Measures to achieve ventilation 
target (PaCO2 <8 kPa)
Spontaneous breathing ↑ Decrease of sedation Not used
Mandatory ventilation ↑ Shortening of inspiratory time Increase of the set mandatory rate
Weaning
Inspiratory pressure ↓ to 20 cmH2O to 20 cmH2O
FiO2 ↓ to 0.35 to 0.35
T-piece trials applied with CPAP T-piece trials applied with CPAP
Definition of abbreviations: PEEP = Positive end expiratory pressure; Pplat = Inspiratory plateu pressure; 
PV-curve = Pressure-Volume-curve; UIP = Upper inflection point of the PV-curve; FiO2 = Fraction of 
inspired oxygen; IRV = Inverse ratio ventilation; CPAP = Continuous positive airway pressure.
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lasted approximately 6 h, and the patients 
were kept supine at least 6 h before the next 
assessment. In case of critical posture-de-
pendent hypoxemia, the duration of prone 
positioning was extended.
4.3.4 General care
Excluding the prone-position periods, 
patients were nursed in a 30 % semi-re-
cumbent position. Fentanyl was infused 
for analgesia, based on clinical subjective 
assessment of pain. Excessive ventilatory 
drive was also an indication for increasing 
the fentanyl dosage. In patients ventilated 
with APRV, fentanyl dosage was reduced 
if spontaneous breaths were suppressed. 
Propofol was infused for sedation based 
on underlying disease as clinically needed. 
Muscle relaxants were given only for the 
measurement of lung mechanics or oc-
casionally for other procedures such as 
bronchoscopy and tracheostomy. Besides 
prone position, no other nonventilatory 
co-interventions (inhaled nitric oxide, al-
mitrine, or extracorporeal membrane oxy-
genation) for ARDS were used. Prolonged, 
high-dose methylprednisolone treatment 
for late-stage fibroproliferative ARDS was 
used according to a written protocol also for 
the patients in Studies II to IV. 
Other principles of treatment including 
nutrition, haemodynamic management, 
renal replacement therapy, or airway man-
agement were administered according to 
the written protocols of the unit.
4.3.5 Data collection
S II – IV During the study period our 
unit used an automatic patient data man-
agement system (CareVue, Hewlett-Pack-
art, Boston, MA, USA). All physiological 
variables displayed from the multichan-
nel patient monitors (Datex CS  3, Datex-
Ohmed, Helsinki, Finland) are stored in 
the database at a 5-minute sampling fre-
quency. Variables were extracted from the 
patient data management system’s data-
base. A sampling frequency for continuous 
variables was every second hour during 
the first 3 days and every 4 hours during 
days 3 to 7. Median values for physiological 
parameters represent values of each time 
period.
S V Two investigators collected data 
from patient records. Demographical data, 
blood, and bronchoalveolar lavage (BAL) 
culture findings, length of mechanical ven-
tilation, length of ICU stay, development of 
nosocomial infections, and 30-day mortal-
ity figures were collected. On admission, se-
verity of illness was evaluated by the Acute 
Physiology and Chronic Health Evaluation 
(APACHE II), Multiple Organ Dysfunction 
Score (MODS), PaO₂/FiO₂ ratio, and Lung 
Injury Score (LIS). When steroid therapy 
was started, the following data were re-
corded: MODS, PaO₂/FiO₂ ratio, and serum 
C-reactive protein (S-CRP) concentration. 
e same data were collected 3 and 7 days 
thereafter. e corresponding data were 
collected for control patients on days 10, 13, 
and 17 after admission.
4.4 Outcome measures
4.4.1 Ventilator-free days, 
length of stay and mortality 
Ventilator-free days (VFD), the main out-
come variable for Study II, was defined as 
a number of days alive without mechanical 
ventilation between inclusion in the study 
and day 28. If a patient died before day 
28 and had not been weaned, VFD was 0. 
Extubation or decanylation for 24 h was 
considered as a day without mechanical 
ventilation. Use of VFD allows a smaller 
sample size and has been advocated as 
a good surrogate measure for mortal-
ity in interventional trials of critical illness 
(Schoenfeld, et al. 2002).
Length of ICU stay was calculated as 
whole days from admission to discharge or 
to death of the patient. Mortality data was 
checked from hospital records, and one year 
outcome by telephoning to patients who, 
according hospital records, were still alive. 
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4.4.2 Assessment of organ failures
Demographical data was collected dur-
ing the first 24 hours after admission 
to ICU. Severity of illness was assessed 
by using APACHE II score (Knaus, et al. 
1985). Assessment of organ failures was by 
Multiple Organ Dysfunction Score (MODS) 
(Study V) (Marshall, et al. 1995) and SOFA-
score (Vincent, et al. 1996) (Studies II to 
IV). Severity of lung injury was assessed 
by Lung Injury Score (Murray, et al. 1988). 
Evaluation of chest x-rays was performed by 
a radiologist blinded to the randomisation.
4.4.3 Physiological variables
Haemodynamic measurements were 
performed based on the information from 
arterial cannulae and pulmonary artery 
catheters. Side-stream spirometry (MCOVX, 
Datex-Ohmeda, Helsinki, Finland) inte-
grated into a patient monitor (CS/3, Datex-
Ohmeda, Finland, Helsinki) served for 
monitoring of ventilatory variables: minute 
ventilation (MV), tidal volume (TV), frac-
tion of inspired oxygen (FiO₂), end-tidal CO₂ 
(ETCO₂), PEEP, and Pinsp. Arterial blood 
gases were determined by use of standard 
blood gas electrodes. All measurements 
were made under stable conditions. 
4.4.4 Computer tomography 
and analysis 
CT examinations were performed dur-
ing transient neuromuscular blockade 
(rocuronium bromide; Esmeron, Organon 
Teknika) to prevent any breathing ef-
forts during scanning. CT scanning was 
performed during manual end expiratory 
breathhold at 10 cmH₂O of PEEP. Apnoea 
was verified by monitoring airway pressure 
during the CT acquisition.
CT was performed with a commercial 
spiral one-detector device (Somatom Plus 4 
Power, Siemens, Erlangen, Germany), scan-
ning from the apex of the lung below the 
diaphragm with a continuous spiral tech-
nique. Tube voltage was 120 kV and current 
was 171 mA, with a pitch of 1, slice thickness 
of 10 mm. All CT data were stored on optical 
discs enabling off-line analysis.
Quantitative analysis of the CT images 
was performed by a radiologist blinded to 
the modes of ventilation. Window widths 
of 1600 Hounsfield units (HU) and a level 
of  – 700 HU sereved for the assessment. Two 
CT sections were selected at two levels (lung 
hilum 3 cm below the carina and basal lung 
areas 3 cm above the diaphragm). e lung 
region-of-interest (ROI) was manually de-
lineated along the inside of the ribs and the 
inner boundary of the mediastinum. Total 
areas and areas of different CT attenuation 
were analysed by the commercial Siemens 
CT workstation. CT attenuation values 
between  – 1000 and  – 512 were considered 
normally aerated, values between  – 512 
and  – 100 HU poorly aerated, and those 
between  – 100 and +100 as nonaerated or 
consolidated. e proportion of each CT at-
tenuation value range of the total lung area 
at each level measured was calculated, and 
also mean CT density at each measured lev-
el. Changes in HU values measured at both 
time-points (days 1 and 7) were assessed.
4.5 Statistical methods
S II – IV e patients were ran-
domised by a concealed allocation ap-
proach with sealed envelopes provided by 
an independent statistician. e primary 
endpoint of Study II was number ventila-
tor-free days, defined as number of days the 
patient is breathing without assistance from 
randomisation to day 28. Prestudy calcula-
tions of ventilator-free days with ALI/ARDS 
patients in our department revealed mean 
10.2 days with SD 2.9. According routine 
methods (power of 80 % and p-value less 
than 0.05) sample size calculations yielded 
a sample size of 40 patients per group to de-
tect a 15 % difference in ventilator-free days 
between study groups, and thus the targeted 
sample size was set at 80 patients.
Outcome measures and continuous 
physiological variables are presented as 
mean and standard error of mean. For com-
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parisons, the Fisher Exact test and Mann-
Whitney test were used when appropriate. 
Multiple logistic regression analysis served 
to test the independent effect of APRV, of 
age and of APACHE II score, each as a deter-
minant of outcome. A p-value less than 0.05 
was considered to indicate statistical signifi-
cance. Statistical tests were performed with 
SPSS 11.1 (SPSS Inc, Chicago IL, USA) and 
with SigmaPlot.
For Studies III and V, post hoc analysis 
was made in order to evaluate the pos-
sibility of too small a sample size. For that 
purpose, the 95 % confidence interval was 
calculated for a difference in the means of 
main outcome variables (ventilator-free 
days in Study II and decrease of nonaer-
ated lung in Study IV) between the groups 
(Gardner 1988).
S V e convenience sample cover-
ing past 5 years was set. All data were ex-
pressed as means with standard deviation. 
Continuous non-paired variables were 
tested with the Mann-Whitney independent 
rank sum test and categorical data with the 
Fisher exact test (2-tail). A probability level 
of less than 0.05 was considered significant. 
Statistical tests were performed with BMDP 
1.1 version for Windows (BMDP Statistical 
Software Inc., Los Angeles, CA, USA)
4.6 Ethical aspects
For the case report in Study I, consent 
was obtained from patients´ next of kin. 
Approvals for Studies II to IV were provided 
by the Ethics Committee of the University of 
Helsinki Central Hospital, the Division of 
Anaesthesia and Intensive Care Medicine. 
Informed oral and written consent was ob-
tained from the next of kin. Because Study 
V was retrospective, the Ethics Committee 
waived the need for informed consent.
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5. RESULTS
5.1 Feasibility of APRV and PP 
in severe ARDS 
APRV and extended PP episodes were com-
bined for one patient with severe ARDS. A 
14-year old patient, after severe skin injury 
and septic shock, developed multiple or-
gan dysfunction, including severe ARDS. 
Ventilatory strategy consisted of lung-pro-
tective ventilation, permissive hypercapnia 
and prone positioning. Due to high ventila-
tory drive and difficulties in adapting to the 
ventilator, the ventilation mode was changed 
to APRV, allowing the patient’s unrestricted 
spontaneous and unsupported breathing 
superimposed on mechanical ventilation. 
After application of APRV, dramatic im-
provement in oxygenation occurred. e 
patient eventually recovered and after 25 
days of mechanical ventilation could be ex-
tubated. Combination of APRV and PP was 
thus feasible, and this experience generated 
the hypothesis that this combination may 
have beneficial, synergistic effects.
5.2 Impact of ventilatory mode on 
respirator free days and mortality
For comparative studies between APRV and 
SIMV, a total of 58 patients were enrolled 
and randomised. Demographical data 
at inclusion are presented in Table 7. No 
differences in any demographical or prog-
nostic parameters were detected between 
groups. e median length (± SEM) of me-
chanical ventilation prior to the start of the 
randomised ventilatory strategy was 39.1 
(± 2.3) hours in the whole study population 
with no difference between groups. Delays 
were caused by referral of the patient from 
another hospital, obtaining the consent, 
and diagnostic procedures during the sta-
bilization phase.
e primary outcome measure was 
number of ventilator-free days after 
randomisation. An interim analysis, per-
formed after analysis of two-thirds of the 
estimated 80 patients, revealed that the 
APRV strategy would achieve no significant 
difference within the planned frame of the 
study. erefore, the study was terminated 
as futile.
Numbers of ventilator-free days were 
comparable: in the APRV group 13.4 (± 1.7) 
and in the SIMV group 12.2 (± 1.5) (p = 0.83). 
Numbers of ICU-free days out of 28 days 
were also similar: 11.9 (± 1.7) in the APRV 
group and 10.7 (± 1.4) in SIMV group. e 
difference in means for respirator-free days 
was 1.2 days with a 95 % confidence interval 
between  – 3.4 and 5.7 days.
Mortality at day 28 was 5 of 30 (17 %) in 
the APRV group and 5 of 28 (18 %) in the 
SIMV group (p = 0.91). Mortality at one 
year was 21 % in all patients: 17 % (5 of 
30) and 25 % (7 of 28) (p = 0.43). Survival 
curves and proportion of patients breathing 
without ventilator are presented in Figure 5. 
Development of organ failure was assessed 
by counting the change in SOFA score be-
tween randomisation and day 7. e SOFA 
score decreased by 2.8 (± 0.8) in the APRV 
group and by 1.7 (± 0.2) in the SIMV group. 
e LIS score decreased during the first 7 
days 0.8 (± 0.1) points in the APRV group 
and 0.6 (± 0.2) points in the SIMV group.
5.3 Impact of ventilatory mode on 
gas exchange, haemodynamics, 
and sedation
Ventilatory variables during stabilisation 
and the first 7 days after randomisation are 
presented in Figures 7 and 8. During the 
stabilization phase, PaO₂/FiO₂ ratio in the 
SIMV group (21.9 ± 1.4 kPa) and in the APRV 
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group (20.0 ± 1.4 kPa) were comparable (p 
= 0.213). Changes in PaO₂/FiO₂ ratio after 
randomisation were comparable, as well 
(Figure 6). Tidal volume per body weight 
during the first week was 9.38 (± 0.16) ml/kg 
in the whole population and with no dif-
ferences between groups or with time. In 
both study groups, moderate hypercapnia 
developed during the first study day, and 
PaCO₂ returned towards normal after 4 
days. In both groups, arterial pH remained 
within the normal range during the study. 
Inspiratory pressure was significantly lower 
in the APRV group (25.9 ± 0.6 vs. 28.6 ± 0.7 
cmH₂O) during the first week (p = 0.007). 
Externally applied PEEP did not differ dur-
ing the first week; 11.2 ± 0.3 cmH₂O in the 
APRV group and 11.9 ± 0.3 cmH₂O in the 
SIMV group (p = 0.08). (Figure 7).
Haemodynamic data are summarized 
in Table 9. Each patient had an indwell-
ing pulmonary catheter during the first 3 
days. Pulmonary artery wedge pressures 
and cardiac indexes between groups were 
comparable during the first week, as was 
the number of patients receiving cathechol-
amines ;. at study entry 96 % of the patients 
in the APRV group and 93 % of patients in 
the SIMV group received cathecholamines. 
At day 7, nine patients of the 24 patients 
alive in the APRV group and 12 of 24 in 
the SIMV group were recieving vasoactive 
medication.
Use of sedatives (propofol) and analgesics 
(fentanyl) is presented in Figure 8. Dosages 
of analgosedatives between the groups were 
comparable. Prone positioning was part of 
the protocol as an adjunctive treatment, 
applied in a similar fashion in both groups. 
During the first week, patients in the APRV 
group spent 30.5 (± 5.1) hours in the prone 
position and those in the SIMV group 30.3 
(± 4.5) hours (p = 0.11).
5.4 Impact of ventilatory mode on 
response to prone positioning
After 45 patients were enrolled in the study, 
a predetermined subanalysis compared 
the combined effects of prone positioning 
and ventilatory mode. e 33 of these 45 
patients, turned prone after the start of the 
randomised ventilation strategy were in-
cluded in the analysis. For these 33, the first 
and second prone episodes were analysed, 
comprising 61 episodes (27 episodes in the 
APRV group and 34 episodes in the SIMV 
group). Demographic factors, degree of 
oxygenation impairment, severity of illness, 
haemodynamic profile, period of prior me-
Figure 5. Survival and ventilator free days. (Figure 4 from Study II).
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Figure 6. PaO2/FiO2 ratio during the first 7 days. (Figure 2 from Study II).
Figure 7. Inspiratory pressure (Pplat) and PEEP during first seven days. 
* = significant differece between the groups. (Figure 1 from study II).
Figure 8. Consumption of propofol and fentanyl during the first 7 days. 
(Figure 3 from Study II).
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chanical ventilation, and type of lung injury 
were in both groups comparable (Table 7).
e interval from randomisation to the 
first prone episode was 5.0 h (median) for 
all patients, with no differences between the 
groups. Interval to the second prone epi-
sode was 24.9 h (median). Comparison of 
ventilatory parameters (minute ventilation, 
inspiratory pressure, and tidal volume) and 
dosage of sedatives revealed no significant 
differences between groups.
e median (interquartile range) of the 
PaO
2
/FIO
2
 ratio during the stabilization 
phase was 137 (125 – 173) mmHg in the 
SIMV group and 123 (100 – 150) mmHg in 
the APRV group (p = 0.38). However, after 5 
h (median) of ventilation in the randomised 
ventilatory mode immediately before the 
first prone episode, the PaO
2
/FIO
2
 ratio 
was significantly (p = 0.02) higher in the 
APRV group (Figure 9). At the end of the first 
prone episode, the PaO
2
/FIO
2
 ratio was sig-
nificantly higher in prone position than in 
the supine in both groups. A trend occurred 
towards better oxygenation in the APRV 
group after the first prone episode, but this 
difference was not statistically significant 
(p = 0.06). e response to prone position-
ing in both groups was similar; medians 
for increase in PaO
2
/FiO
2
 ratio were 75.0 
(9.0 – 125.0 mmHg) in the APRV group and 
39.5 (17.75 – 77.5 mmHg) in the SIMV group 
(p = 0.49). is was 44 % in the APRV group 
and 43 % in the SIMV group respectively (p 
= 0.49).
For three patients in the APRV group and 
two in the SIMV-PC/PS group, the PaO
2
/FIO
2
 
ratio improved and was maintained over 
200 mmHg. ereafter, prone positioning 
was no longer indicated, according to the 
protocol. ose patients who were turned 
prone again (16 in the SIMV group and 12 
in the APRV group), showed no difference 
in PaO₂/FiO₂ ratio before the second prone 
episode: 134 (98.3 – 175) in the APRV group 
and 130 (61.0 – 161.8) in the SIMV. At the end 
of the second prone episode the PaO
2
/FIO
2
 
ratio was significantly better (p = 0.01) in 
the APRV-group compared to the SIMV 
group (Figure 10). During the second prone 
episode, the improvement of oxygenation 
(change of PaO
2
/FIO
2
) was also better in 
Table 9. Main haemodynamic variables at inclusion and at days 1, 3, 5, and 7.
Variable n APRV group n
SIMV 
group p-value
Mean arterial pressure, mmHg Inclusion 30 75 (1.65) 28 74 (2.59) 0.75
Day1 30 76 (1.79) 28 75 (1.62) 0.99
Day3 28 83 (2.53) 27 79 (1.87) 0.44
Day 5 25 85 (3.10) 26 83 (2.28) 0.69
Day 7 24 86 (2.65) 24 84 (2.71) 0.52
Pulmonary occulusion pressure, mmHg Inclusion 30 14.8 (0.34) 28 15.1 (0.46) 0.64
Day1 30 14.3 (0.36) 28 14.6 (0.44) 0.43
Day3 27 14.2 (0.55) 26 14.3 (0.39) 0.41
Day 5 23 13.8 (0.50) 26 14.1 (0.55) 0.39
Day 7 21 13.1 (0.61) 21 12.9 (0.49) 0.83
Cardiac index, L/min/m2 Inclusion 30 4.3 (0.19) 28 4.3 (0.15) 0.88
Day1 30 4.6 (0.20) 28 4.3 (0.16) 0.29
Day3 27 4.5 (0.20) 26 4.5 (0.18) 0.90
Day 5 23 4.3 (0.15) 26 4.5 (0.18) 0.24
Day 7 21 4.4 (0.20) 21 4.5 (0.18) 0.98
Values are mean and SEM. Variables analyzed by Mann-Whitney Rank sum test.
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the APRV group (p = 0.02). Stepwise for-
ward logistic multiple regression analysis 
comprising demographic variables (age, 
sex, APACHE II and SOFA day 1), type of 
ALI, supine PaO
2
/FIO
2
 ratio, duration and 
time-delay to prone positioning, and type of 
ventilatory mode revealed that APRV was an 
independent predictor (p = 0.02) of oxygen-
ation index in the prone position.
In post-hoc analysis, the proportion of pa-
tients showing improvement in oxygenation 
in response to prone positioning (at least 
20 % improvement in PaO
2
/FIO
2
 ratio) was 
similar between groups: 74 % in the APRV 
group and 80 % in the SIMV-PC/PS group. 
In these responders, the improvement in 
the PaO
2
/FIO
2
 ratio was significantly (p = 
0.001) larger in the APRV group: (mean ± 
standard deviation) 104.0 ± 50.7 mmHg 
versus 66.9 ± 38.2 mmHg, with all prone 
episodes analysed.
5.5 Impact of ventilatory mode on 
quantitative CT-scanning
In 47 patients, 23 were alive and on a venti-
lator at day 7. All these 23 were eligible for 
analysis. No differences appeared in clinical 
characteristics between groups at inclusion 
and at the first CT scan. 
A trend (p = 0.09) appeared toward lower 
lung density in the APRV group ( – 335 ± 34 
HU) than in the SIMV group ( – 436 ± 43 
HU) at the carinal level. At diaphragmatic 
level, mean CT densities were similar at 
baseline:  – 305 ± 38 HU in the APRV group 
and  – 406 ± 36 HU in the SIMV group (p = 
0.24). At day 7, mean CT densities showed 
Figure 9. First episode of prone positioning. (Figure 1 from Study III).
Figure 10. The second episode of prone positioning. (Figure 3 in Study III).
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no significant differences:  – 378 ± 47 in the 
APRV group and  – 470 ± 49 in the SIMV 
group (p = 0.3). (Figure 11)
e amount of consolidated lung at 
diaphragmatic level in the first CT was 
comparable in both groups: 36 % ± 5.9 % in 
the APRV group and 24 % ± 3.2 in the SIMV 
group (p = 0.23). At the diaghragmatic level 
on day 7 the amount of consolidated lung 
showed no significant difference (24 % ± 
5.3 % and 17 % ± 4.6 %; p = 0.74). In the first 
Figure 11. Mean (± SEM) CT number at carinal and diaphragmatic at day 1 and day 7. 
(Figure 2 from Study IV).
CT scanning, the amount of normally aerat-
ed lung was higher in SIMV group (50.9 % ± 
6.6 %) than in APRV group (33.4 % ± 4.8 %) at 
carinal level (p = 0.04). At day 7, the amount 
of normally aerated lung at carinal level 
was similar: 40 % ± 6.7 % and 59 % ± 8.9 %; 
(p = 0.08). At the diaphragmatic level the 
amount of normally aerated lung was simi-
lar on day 1 (30 % ± 5.1 % and 45 % ± 5.6 %; p 
= 0.13) and on day 7 (38 % ± 7.4 % and 54 % 
± 7.5 %; (p = 0.26). Individual CT scan data 
Figure 12. Individual data on the absolute areas of normally aerated ( – 512 to  – 1000 HU), 
poorly aerated ( – 100 to  – 512 HU), and non-aerated ( – 100 to +100 HU) lung at diaphrag-
matic level at days 1 and 7. (Figure 3 from Study IV).
APRV l, SIMV ¡
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at the diaphragmatic level during day 1 and 
day 7 are presented in Figure 12.
Change between first and the second CT 
scanning at day 7 at diaphragmatic level 
was the primary outcome variable. Changes 
in proportion of atelectatic/consolidated 
lung area in the diaphragmatic CT section 
in both groups were similar. e decrease 
in the extent of nonaerated lung was 12.1 
± 4.3 % in the APRV group and 7.2 ± 5.7 % 
in the SIMV group (p = 0.65). e absolute 
difference of means was 4.9 % with a 95 % 
confidence interval from  – 9.0 to 19.0 %.
For extent of poorly aerated lung, an in-
crease was observed of 4.1 ± 4.4 % in the 
APRV group and a decrease of 2.8 ± 4.7 in 
the SIMV group, a difference not significant 
(p = 0.48). e amount of normally aerated 
lung increased 8.0 ± 4.0 % and 9.3 ± 7.7 % 
(p   =   0.88).
Figure 13. Mean daily dose of methylprednisolone (Figure 1 from Study V).
Table 10. Response to steroid therapy. (Table 4 from Study V).
Steroid therapy (n = 16) Control patients (n = 15) P value
MODS at inclusion 6.6 (2.6) 6.3 (3.3) 0.71
Change in 3 days after inclusion  – 2.0 (0.4)  – 0.4 (0.6) 0.15
PaO2/FiO2 at inclusion 136.9 (48.7) 160.4 (55.0) 0.15
Change in 3 days after inclusion 60.0 (12.9)  – 6.0 (7.6) 0.004
CRP at inclusion, mg/ml 170.3 (47.9) 131.0 (50) 0.03
Change in 3 days after inclusion  – 130.7 (9.1)  – 19.2 (10.1) < 0.001
Length of mechanical ventilation, days 20.5 (2.3) 20.1 (2.7) 0.70
Length of ICU stay, days 20.9 (2.2) 20.8 (2.8) 0.63
30-day mortality 19 % (3/16) 20 % (3/15) 0.82
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5.6 Prolonged methylprednisolone 
treatment in primary ALI
Demographic data and aetiology of ALI were 
presented in Table 7 in Methods. On admis-
sion, at the start of methylprednisolone 
treatment, and on day 10, the groups were 
comparable, and all patients fulfilled the cri-
teria for ALI. e mean (standard deviation) 
start of steroid treatment was on ICU-day 
9.7 (0.7). Mean dose of methylprednisolone 
per day with 95 % confidence interval and 
tapering schedule is in Figure 13.
Changes in certain variables as a re-
sponse to methylpredinolosolone therapy 
is presented in Table 10. e PaO
2
/FiO
2
 
ratio improved within 3 days after the start 
of methylprednisolone treatment compared 
with the ratios of the control patients. 
Significant decreases occurred in MODS and 
CRP. In the length of mechanical ventilation, 
in length of ICU stay, and in 30-day mortal-
ity, no significant differences appeared. 
Infectious complications were similar 
between groups. Frequency of nosocomial 
infections was not significantly higher in the 
steroid group. Autopsies of nonsurvivors 
(three in each group) revealed no clinically 
undetected nosocomial infections. No other 
steroid-related complications; i.e., gastroin-
testinal bleeding or therapy-resistant hyper-
glycaemia, occurred.
To evaluate a more homogenous patient 
group, a subanalysis was conducted involv-
ing patients with microbiologically con-
firmed pneumococcal pneumonia. In 18 
patients who were mechanically ventilated 
for more than 10 days, a positive blood or 
BAL culture for Streptococcus pneumonie 
was identified. Among these patients pro-
longed methylprednisolone therapy was 
given to 11, with the remaining 7 serving as 
controls. In the methylprednisolone group, 
significant improvement was detectable in 
oxygenation and in reduction inmultiorgan 
failure scores.
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6. DISCUSSION
6.1 Maintanence of spontaneous 
breathing during mechanical 
ventilation
is comparative trial between APRV and 
SIMV has been the first randomised and 
controlled trial comparing two partial ven-
tilatory modes in patients fulfilling the crite-
ria of ALI or ARDS. e goal in this investiga-
tion was to assess the potential benefits of 
a ventilator strategy which employs specifi-
cally unsupported spontaneous breathing 
superimposed on mechanical ventilation.
e hypothesis for the potential benefits 
of APRV was based on several experimental 
and clinical studies in which APRV has 
been associated with improved ventila-
tion-perfusion matching, decreased shunt-
ing, and hence, better arterial oxygenation 
(Downs and Stock 1987, Putensen, et al. 
1994b, Räsänen, et al. 1991, Stock, et al. 
1987, Wrigge, et al. 2003). Due to the cyclic 
reduction in intrathoracic pressure result-
ing from spontaneous breathing, venous 
return is enhanced, and filling of the heart 
is also enhanced, which increases cardiac 
output. Improved oxygenation and cardiac 
output results in increased oxygen delivery 
(Putensen, et al. 1999, Wrigge, et al. 2003). 
ese beneficial changes occur even if the 
spontaneous minute ventilation is only 
a very small fraction of the total minute 
ventilation and occurs without a significant 
increase in oxygen consumption due to the 
activity of respiratory muscles (Hörmann, et 
al. 1997). 
Most of these studies have compared 
APRV to a strategy in which the ventilator 
either passively ventilates the subject or 
does the majority of the work of breathing, 
even if the patient initiates some or even 
most of the breaths. In contrast to the pres-
ent prospective long-term study, Putensen 
and co-workers (1999), in a crossover set-
ting compared APRV with spontaneous 
breathing, to PS and to controlled ventila-
tion. When equal pressure limits or minute 
ventilation were used, they found that PS 
ventilation did not differ from controlled 
ventilation in its effects on gas exchange, 
haemodynamics, oxygen delivery, or 
oxygen consumption; beneficial effects in 
these variables were seen only with APRV 
with unsupported spontaneous breathing 
maintained.
In the present study, the level of pres-
sure support in the SIMV group was much 
lower (10 cmH₂O) than was inspiratory 
pressure for controlled insufflations. us, 
spontaneous breathing with a relatively 
low level of PS may have been associated 
with the same physiological benefits as was 
the unsupported spontaneous breathing 
with APRV, because small inspiratory sup-
port compensated for the resistance of the 
intubation tube. e difference between the 
groups may thus have been so small that no 
possible benefit from unsupported breaths 
could be demonstrated. 
In some studies, APRV improved oxygen-
ation during early phases of ALI (Hörmann, 
et al. 1997, Putensen, et al. 2001). In a pro-
spective and crossover study, APRV has 
improved gas exchange and reduced the 
venous admixture in ARDS patients when 
compared to inverse ratio volume-con-
trolled ventilation, an effect observed after 8 
hours (Sydow, et al. 1994). In a recent study, 
Wrigge and coworkers showed in a pig mod-
el with x-ray computer-assisted tomography 
that end-expiratory lung volume increased 
after 4 hours of spontaneous breathing as 
compared with ventilation with equal air-
way pressure without spontaneous breath-
ing. is recruitment was seen as a larger 
amount of normally aerated lung in depen-
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dent lung regions (Wrigge, et al. 2003). In 
the present study, improvement in PaO
2
/
FiO
2
 ratios in the APRV group, albeit not sig-
nificant, was evident after 24 hours, but no 
differences appeared after the fourth day. 
APRV has been compared to totally 
controlled ventilatory support in one 
prospective, randomised clinical trial by 
Putensen and co-workers (2001). In that 
trial, the study population was multiple 
trauma patients at risk for ARDS. In the 
treatment group, APRV was employed very 
early (6 hours) after the start of ventilatory 
support (Putensen, et al. 2001). e present 
study comprised confirmed ARDS patients 
and the delay to start of the ventilatory 
treatment under study was much longer 
(mean 39 hours). Alveolar collapse, the 
hallmark of severe ARDS, develops early in 
the disease process. Once dependent col-
lapse and consolidation have developed, 
they are often very resistant to measures 
to recruit alveoli (Negri, et al. 2002). e 
type of lung injury may also have had an 
impact. In the Putensen study, patients had 
a secondary or indirect type of lung injury. 
Some studies have shown that a lung with 
secondary injury is more easily recruitable 
than a lung with direct or primary injury, 
the type of injury of most of our patients 
(Lim, et al. 2003a, Pelosi 2000). Another 
major difference between the present 
study and the Putensen study was the non-
ventilatory management of the control 
group. Our sedation policy was the same in 
both groups, and long-term muscle paraly-
sis was used in neither group. Both of these 
factors could per se could impact outcome 
variables such as length of mechanical 
ventilation, length of ICU stay, and even 
mortality. In analgosedation, no differenc-
es appeared, which could be explained by 
the fact that the control group also had the 
possibility of triggering the ventilator, and 
this was not suppressed with sedation.
Several limitations of this study should 
be addressed. Either the ventilator used or 
our spirometry technique was unable to 
measure accurately the amount of sponta-
neous ventilation. Measuring spontaneous 
breathing precisely during partial ventila-
tory support is difficult and requires mea-
surement of oesophageal pressure, not fea-
sible in a long-term clinical trial. However, 
meticulous care was taken that patients in 
the APRV group maintained spontaneous 
breathing, and this was verified by the flow 
and pressure tracings of the ventilator. Due 
to variability in inspiratory pressures and 
in inspiratory times because of the use of 
pressure support in the SIMV group, it was 
impossible to compare accurately the mean 
airway pressures between the study groups. 
We thus cannot rule out the possibility that 
mean airway pressures might have differed 
between groups. 
e use of prone position as part of the 
protocol is another confounding factor, 
although the protocol and the actual use of 
PP in both groups were similar. Mean tidal 
volume per body weight was larger than that 
used for the treatment group in the ARDSnet 
study. Plateau pressures in both groups in 
our trial were, however, well below the 35 
cmH
2
O recommended by the consensus 
conference in 1993 (Slutsky 1994). Recently, 
criticism towards the use of very low tidal 
volumes has also appeared (Eichacker, et al. 
2002). Very low tidal volumes may be harm-
ful, especially in patients without severely 
impaired lung compliance (Gattinoni, et 
al. 2003).
Sample size in this APRV vs. SIMV study 
was based on a power analysis with the 
assumption of a decrease in ventilator-
free days of 15 % with APRV. However, the 
study was terminated for futility on the 
basis of an interim analysis, when only 
two-thirds of the estimated 80 patients 
were included. e decision to terminate 
was also based on slow recruitment of 
patients and on the need to change several 
general principles of care. e difference 
in ventilator-free days between the groups 
was 9 % (1.2 days) in favour of APRV, which 
is not statistically significant. However, to 
evaluate the possibility of too small sample 
size, the 95 % confidence interval for the 
difference in ventilator-free days between 
the groups was calculated (Gardner 1988), 
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and analysis showed that the upper limit of 
the confidence interval was 5.7 days, i.e., a 
43 % increase in ventilator-free days with 
APRV over that with SIMV with PS. is 
indicates that the possibility of a clinically 
significant difference between ventilatory 
modes cannot be definitely excluded and 
that the study lacked the power to answer 
the hypothesis posed.
is study also lacked the power to evalu-
ate mortality between groups. However, 
the one-year mortality in our study, 21 % 
for the whole material, is below the range 
of recently published mortality rates (from 
31 to 70 %) in clinical trials and case series 
with ARDS patients (Estenssoro, et al. 2002, 
Milberg, et al. 1995, Valta, et al. 1999). e 
inclusion criteria were those of AECC for 
ALI. However, the criteria were confirmed 
after the standardised stabilisation phase 
including ventilatory management with 
PEEP guided by a PV curve. During this 
phase, fluid homeostasis and haemody-
namics were optimised as guided by PAC. 
us, patients fulfilling AECC ALI criteria af-
ter this period truly represent patients with 
severe lung injury. After this stabilisation 
phase, most patients with a paO
2
/FiO
2 
ratio 
over 200 mmHg could be considered for 
weaning and they were excluded from the 
study. Only a few patients with ALI criteria 
were included and most had a more severe 
type of oxygenation failure, i.e. , ARDS.
6.2 Prone positioning in ALI
Allowing spontaneous breathing during me-
chanical ventilation had an additive effect 
on the improvement in oxygenation in re-
sponse to prone positioning. Improvement 
in gas exchange in the APRV group occurred 
over time and was significant 24 h after the 
shift from totally controlled mechanical 
ventilation. In accordance with several oth-
er investigations, in this study PP improved 
oxygenation in approximately 70 to 80 % of 
the patients with ARDS or ALI (Messerole, 
et al. 2002).
Achievement and maintenance of 
maximal aeration of the lung may be an im-
portant tool for reduction in lung injury re-
lated to mechanical ventilation (Lachmann 
1992). PP has been shown to induce alveolar 
recruitment (Guerin, et al. 1999) and in ani-
mal experiments to reduce VILI (Broccard, 
et al. 2000). However, in the only prospec-
tive study addressing effects of PP on sur-
vival, benefit occurred only in the patient 
group with severe hypoxemia (Gattinoni, 
et al. 2001b). In Gattinoni´s study, PP was 
used only once per day, and the mode of 
mechanical ventilation was controlled ven-
tilation (Gattinoni, et al. 2001b).
Prone position has been proposed to 
change the effect of abdominal mass on 
the dorsal lung (Froese and Bryan 1974). 
By this mechanism, PP reduces trans-
diaphragmatic pressure on the dorsal 
part of the diaphragm. Reduced pressure 
creates better working conditions for the 
diaphragm and enhanced movement of the 
diaphragm during spontaneous breathing, 
and redistributes ventilation towards dorso-
basal lung areas. us, PP and spontaneous 
breathing may thus show synergistic effects 
on recruitment of juxtadiaphragmatic areas. 
However, this theory of the effects of PP 
on intra-abdominal pressure and regional 
ventilation in the basal lung area has been 
challenged (Colmenero-Ruiz, et al. 2001), 
and neither intra-abdominal pressure nor 
lung mechanics during prone positioning 
was measured in the present study. Another 
issue concerning the effects of PP is the ef-
fect of PEEP. Turning a patient prone has 
been shown to induce changes especially in 
chest wall compliance (Pelosi, et al. 1998). 
us, in the prone position, optimal PEEP, 
as well as the effects of spontaneous breath-
ing may differ.
e time period between onset of ARDS 
and the beginning of prone positioning has 
varied considerably (Chatte, et al. 1997, 
Douglas, et al. 1977, Gattinoni, et al. 2001b, 
Langer, et al. 1988). In the present study, the 
effect of prone positioning was employed 
relatively early (27 – 35 h) after ALI onset in 
order to study a patient population in which 
time-related physiological conditions were 
as homogenous as possible. Time-related 
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factors related to PP have been proposed 
to explain the variance in response (Lamm, 
et al. 1994). Similarly, type of ALI may cor-
relate with response to PP (Pelosi 2000). A 
marked oxygenation response occurs signif-
icantly more often in a patient with indirect 
lung injury (Lim, et al. 2001). In the present 
study, most patients had primary ALI, and 
type of lung injury was not an independent 
determinant of change in oxygenation.
6.3 CT scanning in ALI
Lung recruitment as assessed with CT 
scanning densitometry was similar after 7 
days with APRV and with the other partial 
ventilatory mode, i.e., SIMV with pressure 
support. 
Recruitment refers to the opening of 
previously closed alveoli. Quantitative CT 
analysis has been used to investigate this 
phenomenon in various experimental and 
clinical settings (Gattinoni, et al. 2001a) 
(Rouby, et al. 2003a). However, the inter-
pretation that change from consolidation to 
normal aeration as measured with CT den-
sitometric is due to recruitment has been 
recently challenged (Hubmayr 2002). It has 
been proposed that change in CT density in 
one region of interest (ROI) can be due to 
change in alveolar size, i.e., alveolar disten-
sion, or it can be due to change in amount of 
tissue and interstitial fluid or due to alveolar 
flooding (Hubmayr 2002). At present how-
ever, the only clinically available method for 
the measurement of regional air content of 
the lung is the CT densitometry.
Several technical and analytical factors 
influence the CT findings of this study. Only 
two sections of the lung were measured. 
Investigation with CT using more sections 
or whole lung scanning have shown that 
analysis based on only a few slices may 
underestimate changes in lung aeration 
(Malbouisson, et al. 2001a, Puybasset, et 
al. 2000). In volumetric studies, decrease 
in FRC has been greatest in the lower lobes 
(Puybasset, et al. 2000, Rouby, et al. 2003a). 
Because the effect of spontaneous breathing 
is most likely to occur in juxtadiaphragmatic 
slices, the choice of primary endpoint, 
change in nonaerated lung in the basal sec-
tions, is justified. 
Volumetric studies have revealed that 
massive loss of aeration is homogeneously 
distributed, with a slight predominance 
in the upper lobes. On the other hand, in-
crease in tissue volume is heterogeneously 
distributed. In severe ALI, the lower lobes 
are essentially nonaerated, while the upper 
lobes may remain normally aerated. Two 
opposite radiologic presentations, corre-
sponding to different lung morphologies, 
may occur. In patients with focal computed 
tomographic attenuations, the lower lobes 
are entirely atelectatic. In patients with dif-
fuse computed tomographic attenuations, 
lung volume is preserved in the upper lobes 
and reduced in the lower lobes, although 
the loss of aeration is equally distributed 
between upper and lower lobes. When a 
positive intrathoracic pressure is applied to 
patients with focal acute respiratory distress 
syndrome, poorly aerated and nonaer-
ated lung regions are recruited, whereas 
lung regions normally aerated at zero 
end-expiratory pressure tend to be rapidly 
overinflated, increasing the risk for ventila-
tor-induced lung injury (Puybasset, et al. 
2000, Rouby, et al. 2003a). Ventilatory mode 
or position change may produce similar 
physiological consequences. In this study, 
no categorisation based on CT morphology 
was performed.
Respiratory settings during the CT scan-
ning may also have influenced measure-
ment of gas distribution. We investigated 
lungs at expirium during transient relax-
ation given immediately before the scan-
ning. Reduced muscle tone induced by 
neuromuscular blockade can have effects 
on lung volume (Froese 1989). Relaxation of 
the diaphragm could have caused compres-
sion by the abdominal contents in basal lung 
areas and closure of alveolar units. Cephal-
ic movement of the diaphragm could have 
abolished the possible reopening achieved 
by spontaneous breathing (Hedenstierna, 
et al. 1989). Very rapid dynamic or multi-
detector CT scanning would have enabled 
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evaluation without neuromuscular block-
ing drugs and thus would have been the 
method of choice (Markstaller, et al. 2003). 
However, this technology was unavailable at 
the time of this investigation.
6.4 Prolonged methylpredisolone 
in the late-phase of ALI
Prolonged methylprednisolone treatment 
started after 10 days of mechanical ventila-
tion was associated with improved oxygen-
ation and decrease in C-reactive protein 
concentration within 3 days after the start 
of treatment in patients with late-phase pri-
mary ALI. ese findings agree with earlier 
findings regarding effects of glucocortico-
steroids in the late or unresolving phase of 
acute lung injury (Biffl, et al. 1995, Hooper 
and Kearl 1990, Keel, et al. 1998, Meduri, et 
al. 1998a). Such studies with heterogenous 
groups of ALI patients have consistently 
shown improvement in lung function and 
reduction in associated organ failures. 
Optimal timing for the start of cortico-
steroid treatment is a critical issue. Earlier 
studies have investigated the potential of 
high-dose steroids to control the initial 
inflammatory response in sepsis, i.e., in 
patients at risk for ARDS, or in patients 
with ARDS in an early phase of the disease 
process (Cronin, et al. 1995, Lefering and 
Neugebauer 1995). ese studies have 
failed to show any benefit from this early or 
prophylactic immunomodulation (Cronin, 
et al. 1995, Lefering and Neugebauer 1995). 
e pathophysiological basis of late steroid 
therapy does, however, differ. e goal is 
to prevent or alleviate the exaggerated and 
sustained host defence response which pre-
vents effective restoration of lung anatomy 
and function. A protracted inflammatory 
response leads to proliferation of myofibro-
blasts and to collagen deposition in the lung 
parenchyma. Lung fibrosis and alveolar 
obliteration in the lungs lead to deteriora-
tion of oxygenation and of lung mechanics 
(Luce 2002).
Mechanisms regulating development of 
this fibroproliferative process are complex. 
As a measure of inflammatory response 
and fibroproliferation in ARDS, various 
proinflammatory mediators have been 
investigated (Goodman, et al. 1996). Levels 
of interleukin-6 have been found to be 
increased in patients with a tendency to 
develop unresolving ALI. Clinical signs of 
fibroproliferation correlate with levels of 
procollagen types I and III aminoterminal 
propeptides. Steroid therapy is associ-
ated with reduced levels of these markers 
(Meduri, et al. 1998b).
CRP also correlates well with the inten-
sity of systemic inflammatory response 
and can serve as a measure of the effect of 
corticosteroid treatment. Because CRP has 
a special function against pneumococcal 
infections via binding to pneumococcal C-
polysaccharide, following CRP levels may 
offer special attraction for the treatment 
of pneumococcal ALI. In patients with late 
ARDS, glucocorticoid treatment reduces 
levels of several proinflammatory media-
tors and markers of fibroproliferation, sug-
gesting that premature discontinuation of 
steroids can induce a rebound effect and 
an increase in production of cytokines 
(Headley, et al. 1997, Meduri, et al. 1995b). 
Early discontinuation of steroid therapy in 
late ARDS has been associated with dete-
rioration in the clinical status. In the present 
study, methylprednisolone was continued 
at a high dose of 80 to 125 mg/day until a 
clear response was achieved in inflamma-
tory parameters.
Before institution of corticosteroid 
therapy, diagnostic survey has been recom-
mended for untreated infections (Meduri 
1996). In the present investigation, steroids 
were considered only after comprehensive 
antimicrobial therapy which was based on 
culture results or broad-spectrum empirical 
therapy. Detection of occult infection or 
development of nosocomial infection was 
through regular urine culture, and through 
displaced intravenous catheters, brochoal-
veolar lavage, and tracheal suction. Based 
on high degree of clinical suspicion, thoracic 
and abdominal CT-scans were performed.
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6.5 Clinical implications and 
future perspectives
In evidence-based medicine, several treat-
ments applied to critically ill patients in 
ICUs lack even grade-B evidence (Dellinger, 
et al. 2004). is is also still the case with 
most of the treatments applied in ALI/
ARDS. A particular problem in research on 
the critically ill patient is the low signal-to-
noise ratio. Impact of ventilatory treatment 
on mortality is most likely rather small. 
us, several aspects of care and the failure 
to standardise them may easily obscure this 
effect. Development of algorithms to stan-
dardise care, e.g., fluid therapy, treatment of 
any underlying disorder, and several other 
aspects of care, is very difficult.
Nevertheless, over the years, the outcome 
for ALI/ARDS has improved (Milberg, et al. 
1995), and our understanding of the patho-
physiological mechanisms involved has in-
creased enormously. However, major gaps 
still exist. ALI/ARDS is a very complicated 
and multifactorial process, and several 
aspects of treatment are very difficult to in-
vestigate in the frame of a randomised and 
controlled trial. Considering, for instance, 
the fast-evolving possibilities of modern 
ventilator technology, it is probable that the 
outcome benefit of most of these features 
will not be investigated in a randomised 
controlled setting. For this reason it is very 
important to discover reliable surrogates of 
morbity and mortality in ALI/ARDS. Studies 
with reasonable surrogate endpoints and 
physiological measures will continue to be 
important before any new technology is 
employed in critical care. 
Epidemiological data on the clinical 
course of ALI are still scarce, and inci-
dence and risk factors of fibroproliferative 
late-stage ALI poorly known. Employment 
of lung-protective ventilation may have 
an influence on incidence, as will other 
supportive therapies. e pathogenetic 
pathways of the transition from acute 
alveoli-endothelial injury to the late prolif-
erative phase may vary depending on initial 
cause of lung injury. Indirect (secondary 
or extrapulmonary) and direct (primary 
or pulmonary) insults may lead to differ-
ing pathophysiological types of ALI (Pelosi 
2000). Due to the complex pathogenesis of 
ALI, especially studies concerning effects of 
immunomodulative therapy should focus 
on a homogenous group of patients. is 
poses a logistical challenge when patients 
with comparable underlying conditions 
and during the same phase of the disease 
process must be included in the study. With 
a relatively rare condition such as late-stage 
ARDS, this can be very difficult even with 
large-scale multicenter trials.
Despite the lack of large-scale prospec-
tive randomised trials, steroids are nowa-
days widely used in late phase ALI/ARDS. 
e ARDS network consortium has been 
conducting a trial testing the effects of 
methylprednisolone in a heterogeneous 
group of patients with late phase ARDS 
(Anonymous 2004).
e effects of ventilatory treatment 
should also be investigated in a homog-
enous patient group. Data from CT scan-
ning studies suggest that lung morphol-
ogy may have implications for selection of 
ventilatory settings (Rouby, et al. 2003b). 
Development of on-line monitoring of lung 
mechanics and bed-side tools to investigate 
more precisely regional ventilation may 
help in selecting individual settings for each 
patient which will cause the least mechani-
cal stress on injured lungs (Hedenstierna 
2004, Stenqvist 2003).
APRV offers physiological benefits dem-
onstrated in several trials discussed here. 
Although the results of this investigation 
concerning primary outcome measures did 
not differ from those of current practice, 
some clinical implications can drawn. 
APRV is a very flexible ventilatory mode. 
Without changing ventilatory mode, the 
amount of mechanical support can be 
adjusted from almost total mechanical 
support (total support is not APRV by 
definition) to CPAP with the total work of 
breathing done by the patient. Logistically, 
continuous monitoring of the weaning pro-
tocol is simple and may offer advantages in 
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everyday clinical practice. APRV is suitable 
for most ALI patients. Benefits in renal and 
gut perfusion should be tested in a patient 
population in which these issues could 
have special implication for the outcome. 
Sedation consumption did not differ in this 
study, a finding that should be investigated 
further with a strict sedation policy and 
precise monitoring of sedation.
e best evidence for supportive treat-
ment of ALI/ARDS are the data from the 
ARDSnet trial (Anonymous 2000). is in-
vestigation has raised several questions con-
cerning ethics and the planning of studies 
with the critically ill (Miller 2004, Steinbrook 
2003). Very important is the management of 
the control group: Treatment of the control 
group should represent current routine 
practice. Otherwise positive results of a trial 
may be interpreted as a harmful effect im-
posed upon the control group, as has been 
the case with the ARDSnet study (Eichacker, 
et al. 2002). In the future, selection of treat-
ment options for the control group must 
be even more carefully justified and truly 
represent the current gold standard.
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7. CONCLUSIONS
On the basis of these studies the following conclusions can be drawn:
1. In ALI patients, primary use of APRV with maintained unsupported 
spontaneous ventilation as compared to SIMV with PS
  a. is feasible and potentially beneficial in severe ALI.
  b. does not increase the number of ventilator-free days.
  c. does not improve variables of gas exchange and haemodynamics.
  d. does not reduce sedative use.
2. Prone positioning and allowing spontaneous breathing during APRV 
have advantageous synergistic effects on gas exchange.
3. e effects of APRV with spontaneous breathing and SIMV with pressure 
support on lung aeration, as measured by CT after 7 days of mechanical 
ventilation, do not differ significantly.
4. In patients with primary ALI, prolonged methylprednisolone therapy, 
begun 10 days after the start of mechanical ventilation, improves 
gas exchange and is associated with a decrease in multiple organ 
dysfunction.
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